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EXECUTIVE SUMMARY 
 
 
Chapter 1: Introduction and Background 
 
• The importance of utilising health research in policy-making, and therefore the need to 
understand the mechanisms involved, is increasingly recognised. Recent reports calling 
for more resources to improve health in developing countries, and global pressures for 
accountability, draw greater attention to research-informed policy-making. 
  
• For at least twenty years there has been recognition of the multiple meanings or models 
of research utilisation in policy-making. It has similarly been long recognised that a range 
of factors is involved in the interactions between health research and policy-makers. 
 
• The emerging focus on Health Research Systems (HRS) has identified additional 
mechanisms through which greater utilisation of research could be achieved. 
Assessment of the role of health research in policy-making is best undertaken as part of 
a wider study that also includes the utilisation of health research by industry, medical 
practitioners, and the public. 
 
 
Chapter 2: The Nature of Policy-Making, Types of Research and Utilisation Models 
 
• Policy-making broadly interpreted includes national health policies made by government 
ministers and officials, policies made by local health service managers, and clinical 
guidelines from professional bodies. In this report, however, the main focus is on public 
policy-making rather than that conducted by professional bodies. The utilisation of health 
research in policy-making should eventually lead to desired outcomes, including health 
gains. Research can make a contribution in at least three phases of the policy-making 
process: agenda setting; policy formulation; and implementation. Descriptions of these 
processes, however, can over-estimate the degree of rationality in policy-making. 
Therefore, the analysis is informed by a review of the full range of policy-making models. 
These include rational and incrementalist models. 
 
• Various categories of research are likely to be used differently in health policy-making. 
Applied research might be more readily useable by a policy system than basic research, 
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but health policy-makers tend to relate more willingly to natural sciences than social 
sciences. When research is based on the priorities of potential users, and/or is research 
of proven quality, this increases the possibility that it will be translated into policies. 
There also appears to be a greater chance of research being used in clinical policies 
about delivering care to patients, than in national policies on the structures of the health 
service. 
 
• Models of research utilisation in policy-making start with a link to rational or instrumental 
views of policy-making, and include descriptions of how commissioned research can 
help to find solutions to problems. Other models relate to an incrementalist view in which 
policy-making involves a series of small steps over a long period; research findings might 
gradually cause a shift in perceptions about an issue in a process of ‘enlightenment’. 
Interactive models of research utilisation stress the way in which policy-makers and 
researchers might develop links over a long period. Research can also be used 
symbolically to support decisions already taken.  
 
 
Chapter 3: Examples from Previous Studies 
 
• A study of health policy-making in two southern African countries illustrates how policy-
making processes can be analysed. It addresses agenda setting, policy formulation and 
implementation. The methods used included documentary analysis and key informant 
interviews. 
• Many previous studies of research utilisation can provide lessons for future 
assessments. Two broad approaches can be identified. Some studies start with pieces, 
or programmes, of research and examine their impact. Others consider policy on a 
particular topic and assess the role of research in the policy-making. There are 
advantages and drawbacks in each approach, and overlaps between them. 
 
• To facilitate comparison, studies of research utilisation are best organised around a 
conceptual framework. Despite that, the influence of contextual factors in different 
settings makes it difficult to generalise. 
  
• The two methods used most frequently, and usually together, come from the qualitative 
tradition: documentary analysis and in-depth interviews. Questionnaires, bibliometric 
analysis, insider knowledge and historical approaches have all been applied. A few 
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recent studies have attempted to score or scale the level of utilisation. 
 
• The examples suggest there is a greater level of utilisation and final outcomes in terms 
of health, health equity, and social and economic gain than is often assumed, whilst still 
showing much underutilisation. There is considerable variation in the degree of 
utilisation, both within and between studies. 
 
 
Chapter 4: Key Issues in the Analysis of Research Utilisation in Policy-Making 
 
• Increasing attention is focusing on the concept of interfaces between researchers and 
the users of research. This incorporates the idea that there are likely to be different 
values and interests between the two communities.  
 
• In relation to utilisation, the prioritisation debate revolves around two key aspects: 
whether priorities are being set that will produce research that policy-makers and others 
will want to use, and whether priorities are being set that will engage the interests and 
commitment of the research community. 
 
• Interactions across the interface between policy-makers and researchers are important 
in transferring research to policy-makers. This fits especially well with the interactive 
model of utilisation. Actions by individual researchers can be useful in generating 
interaction, but it is desirable to consider the role of the HRS in encouraging or facilitating 
interactions, networks and mechanisms at a system-wide level. The HRS could provide 
funding and organisational support for various items including: long-term research 
centres; research brokerage/translator mechanisms; the creation of official committees of 
policy-makers and researchers; and mechanisms for review and synthesis of research 
findings. 
 
• There is increased recognition of the significance of policy-makers in their role as the 
receptors of research. In relation to the perspective of policy-makers there is a spectrum 
of key questions. These range from whether relevant research is available and 
effectively being brought to their attention, to whether they are able to absorb it and 
willing to use it. The HRS has a responsibility, especially in the early parts of the 
spectrum, but the wider health system also has a responsibility to create appropriate 
institutional mechanisms and ensure there are staff willing and able to incorporate 
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relevant research. 
 
• More attention should be given to the role of incentives, both for researchers to produce 
utilisable research, and for policy-makers, at the system or individual level, to use it. The 
assessment of utilisation becomes a key issue if rewards are to focus on relevance as 
well as research excellence.  
 
• An appropriate model for assessing research utilisation in policy-making combines 
analysis of two issues: the role of receptors and the importance of actions at the 
interfaces. An emphasis on the role of the receptor is necessary because ultimately it is 
up to the policy-maker to make the decisions. Any assessment of the success of the 
HRS in relation to utilisation must accept that the wider political context is beyond the 
control of the HRS, but consider the activities of the HRS, within its given context, to 
enhance the utilisation of research by increasing the permeability of the interfaces. 
 
 
Chapter 5: Assessment of Research Utilisation in Health Policy-Making 
 
• The reasons for assessing the utilisation of research in policy-making include: advocacy, 
accountability, and increased understanding. For the World Health Organization there 
could be a role in conducting such assessments with the aim of providing evidence of the 
effective use of research resources. This could support advocacy for greater resources 
to be made available for health research. It is important that the purposes of any 
assessment are taken into account in planning the methods to be used. 
 
• Previous studies demonstrated the difficulties of making generalisations about specific 
factors associated with high levels of utilisation. To address this in any cross-national 
WHO initiative involving a series of studies in a range of countries, it would be desirable 
to structure all the studies around a conceptual framework (such as the interfaces and 
receptor framework considered here) and base the studies in each country on common 
themes. These could include policies for the adoption of multi-drug therapy for treating 
leprosy, and for the equitable access to health services. 
  
• Analysis of documents and semi-structured interviews would be appropriate methods in 
each study assessing the role of research in policy-making on a specific policy theme. 
Questionnaires could also have a role. These approaches would provide triangulation of 
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methods and data-sources and should also provide material to help identify the relative 
importance, in relation to the level of utilisation recorded, of the HRS mechanisms 
described in the previous analysis. The types and sources of research used, and 
reasons for their use, should also be recorded and attempts made to correlate them with 
the previous priority setting approaches. It is expected that each study will produce its 
own narrative or story of what caused utilisation in the particular context, but the data 
gathered could also be applied to descriptive scales of the level research utilisation. The 
four scales could cover the consistency of policy with research findings, and the degree 
of influence of research on agenda setting, policy formulation, and implementation. 
  
• The findings from the assessments in each participating country should be collated. For 
each policy theme or topic the analysis would compare two sets of data: the scales for 
level of research utilisation in each country, and the contextualised lists of the HRS 
activities and other mechanisms and networks thought to be important. Although the 
account here has focused on research impact on policy-making, the evaluations would 
be stronger as part of a wider analysis covering research utilisation and interactions with 
practitioners, industry and the public. 
 
• Given appropriate and targeted topic and country selection, this approach is likely to 
meet the purpose of using structured methods to provide examples of effective research 
utilisation. The approach should contribute towards enhanced understanding of the 
issues and could provide the basis of an assessment tool which, if used widely in 
countries, could lead to greater utilisation of health research. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
 
The Director General of the World Health Organization (WHO) has decided that the World 
Health Report 2004, Health Research: Knowledge for Better Health, should involve a careful 
reflection of how advances in health research lead to improved health and health equity. The 
WHO has launched a broad Health Research Systems Analysis (HRSA) Initiative that will 
inform the 2004 report. One component of this initiative is a project focusing on the 
assessment of health research utilisation. The utilisation project itself consists of various 
elements. This paper was commissioned by the Research Policy and Co-operation 
Department of WHO, Geneva, to review the issues related to the utilisation of health 
research in policy-making, and, based on that review, make recommendations about 
appropriate methods for assessment of such utilisation. 
 
WHO is giving increased emphasis to the role of health systems [1] and attention is focusing 
on the importance of policy-making in achieving effective health systems [2,3]. The World 
Bank made estimates of the costs of attaining the health-related Millennium Development 
Goals of between $20 and $25 billion a year. However, the report notes that: ‘these unit cost 
estimates only apply when the policy and institutional environment is conducive to additional 
health spending being effective’ [2]. The importance of health policy–making, in turn, being 
research-informed is recognised by a growing number of bodies [3-5]. 
 
The existence of relevant research, though necessary, is not sufficient. Evidence-based 
policy is difficult to achieve and it is widely agreed that health policies do not reflect research 
evidence to the extent that in theory they could [5-11]. Examination of the policy-making 
process confirms it to be extremely complex, with many genuine obstacles to evidence-
based policy-making at the same time as there are factors that could increase research 
utilisation. A full review of the many possible meanings of research impact reveals that there 
may be more utilisation in policy-making than is sometimes recognised. Such a review also 
enhances understanding of the issues, including the differential scope for utilisation 
associated with different types of research and policy environments. Developing a 
conceptual framework of the processes of utilisation should assist with the formulation of 
assessment tools that reveal the full picture of the way research is used in policy-making. 
Furthermore, it should allow the growing demands for accountability for research 
expenditure [12-18] to be addressed appropriately, which could also be of benefit to the 
research community. 
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 There is a rich background of material for each of these areas, including key contributions 
from Weiss identifying the multiple meanings that can be attached to research utilisation in 
policy-making [19]. Their importance lies in the fact that some of these meanings, or models, 
point to less obvious patterns of use than those suggested by instrumental research 
exploitation which involves research findings being directly used in policy formulation.  
 
About twenty years ago there was recognition of the need for analysis to combine a range of 
factors such as the nature of different types of health research knowledge and the diverse 
institutional arrangements for policy-making. In their assessment of the attempt in the 1970s 
to increase utilisation of research funded by the UK’s Department of Health, Kogan and 
Henkel found, ‘the interconnections between epistemologies and institutional relationships 
were a recurring theme’ [7]. The importance of interactions across the interfaces between 
researchers and policy-makers was identified. The role of policy-makers as the receivers, or 
receptors, of research and the need for careful priority setting were highlighted. Various 
elements of this analysis were recently reported also to be relevant for health research in 
Mexico [10].  
 
The context of the current move to attempt to increase research utilisation is important. 
There is now a broad coalition pressing for improvements. Various organisations came 
together in 2000 to support the formation of the Alliance for Health Policy and Systems 
Research with its 300 partner institutions. It aims to promote capacity building for, and the 
dissemination and impact of, research both on and for policy [20]. At the level of specific 
programmes within international bodies, there is a growing stress on the role of policy-
making: ‘Research on implementation, on policy-making or programme development is as 
important as basic clinical research for improving child health’ [21]. Recent weeks have seen 
publication of the first systematic review to address research utilisation in policy-making [22]. 
Furthermore, the developing interest in research informed policy-making coincides with the 
extensive efforts being made to increase the implementation of health research findings 
more generally. Indeed, the emphasis on evidence-based medicine is itself generating extra 
pressure from practitioners that policy-makers, too, should have a duty to consider research 
evidence [23]. The role of research utilisation in policy-making is seen as a key element in 
the growing interest within WHO on research utilisation and its assessment [3,24]. 
  
A further important part of the context is that developments in the UK in the 1970s, and in 
other European countries [25], could be seen as early attempts to develop a system to 
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augment the traditional individualistic determination of medical research priorities in 
universities and hospitals. A similar emphasis on issues such as priority setting is seen in 
recommendations made for middle and low income countries by the Commission on Health 
Research for Development [26]. The concept of Health Research Systems (HRSs) is now of 
growing significance [27]. One of the main elements that distinguishes a HRS is the attempt 
to develop mechanisms and networks to facilitate the greater use of health research. 
 
Building on the above analysis, it is our contention that many factors need to be brought 
together if assessment of research impact on policy-making is to contribute to an 
understanding of the issues and an enhancement of utilisation. The prime focus should be 
the policy-maker. This paper first examines the concept of policy-making, and the underlying 
assumption that it is better if it is research-informed. Then we consider the range of types of 
health research and the levels of policy-making at which they could be applied. These 
strands are brought together to provide an analysis of the wide range of ways in which 
research can have an impact on health policy-making.  
 
The focus then moves to examining contributions from previous studies of knowledge 
utilisation in health policy-making, including those using standardised measures. Various 
dimensions of our conceptual analysis form the next sections. We start with the interfaces, 
both at the priority setting stage and when findings are communicated between researchers 
and policy-makers. The role of policy-makers as receivers, or receptors, of research is 
examined along with the accompanying institutional arrangements. Incentives are also 
important. The material is brought together in a wide-ranging interfaces and receptor model 
of research utilisation in policy making. Finally, the various possible purposes of assessment 
of research utilisation are considered before suggestions are made about suitable methods 
for assessing the impact of research on policy-making. Such assessments would be best 
undertaken as part of a wider evaluation of the utilisation of health research by industry, 
medical practitioners and the public. 
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CHAPTER 2: THE NATURE OF POLICY-MAKING, TYPES OF RESEARCH, AND 
UTILISATION MODELS 
 
2.1 The Nature of Policy-Making and its Role in Knowledge Utilisation 
Policy-making can be viewed as involving the ‘authoritative allocation of values’ [28], and 
when interpreted broadly can include people making the policy as government ministers and 
officials, as local health service managers, or as representatives of a professional body. 
Policy-making involves those in positions of authority making choices that have a special 
status within the group to which they will apply. The results take many forms ranging from 
national health policies made by the government to clinical guidelines determined by 
professional bodies. This broad usage of the term policy-making has advantages when 
conducting knowledge utilisation or payback assessments, and has contributed to a 
conceptual framework for a series of such studies [14,17,29]. In this report, however, the 
analysis mainly concentrates on public policy-making rather than that undertaken by 
professional bodies. 
 
The framework consists of two elements. These are a multidimensional categorisation of 
benefits from health research, going through from the primary and secondary outputs to the 
final outcomes, and a model of how to assess them.  A revised version of the model is 
shown as Figure 1 and consists of a series of stages. This sequence can be useful when 
examining how a health research project could be utilised, in policy-making and practice, in 
ways that result in final outcomes such as health gains and economic benefits. Public 
engagement with research can play a key role in research utilisation. The model 
incorporates the concept of the stock, or pool, of knowledge and the idea that there are 
various interfaces between research the wider political, professional and social 
environments. These points, together with various feedback loops and forward leaps, mean 
that although the stages are presented in a linear form, the model recognises that the actual 
steps involved in utilisation and achieving final outcomes are often multidirectional and 
convoluted. That said, the model helps both to organise assessments and to indicate where 
the various elements of the multidimensional categorisation of benefits might occur.  
 
The framework is also important for the structure of this report because it demonstrates that 
assessment of research impact on policy-making is best undertaken as part of a wider 
analysis of the utilisation of research. Throughout the paper it will become increasingly clear 
that policy-making is itself influenced by industry, by health professionals who might be 
expected to apply research findings in their practice, and by the public who might engage       
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Figure 1:  The Place of Policy-Making in the Stages of Assessment of Research Utilisation and 
Final Outcomes 
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with research, either as patients or more generally in society. The interaction of all these 
groups with research findings is an important consideration and the interfaces operate at 
many levels.  
 
In terms of the utilisation of the knowledge, research-informed policies can be referred to as 
secondary outputs from research [14]. This distinguishes them from the primary, or direct, 
outputs of research processes such as journal articles, other publications, and trained 
researchers. Neither, however, are the policies the desired final outcomes; they represent a 
step in the process. It is sometimes possible to identify how research findings have informed 
policy-making even when it might be extremely difficult to trace influences at other stages in 
the utilisation processes. Furthermore, the approach enables the processes of research 
utilisation to be identified in ways that would be impossible if the analysis attempted to jump 
immediately to the final outcomes. In particular, detailed analysis at this stage can address 
the counterfactual, ie consider what might have happened without the relevant research: 
would the policy have been changed anyway?  
 
Not all examples of health knowledge utilisation go through a policy-making stage, and in 
some cases the policy comes after partial translation of the findings into practice. For 
example, clinical guidelines are usually developed after leading clinicians in the field have 
already adopted an evidence-based practice and then seek to encourage its wider diffusion 
throughout the profession. Nevertheless, often a policy-making stage in knowledge utilisation 
is important if the final outcomes of health, health equity, and social and economic gain are 
to be achieved. 
 
A positive case can be set out for the contribution research can make to policy-making. The 
basic assumption of knowledge utilisation related to policy-making is that policies which are 
research informed will be better than otherwise would have been the case. It is assumed that 
research exposes policy-making to a wider range of validated concepts and experiences 
than those that can be drawn from the normal time-limited and politically constrained 
processes of policy deliberation. It thus allows a broader choice of policy options to emerge.  
Research often enables policies to be generated upon technically well-informed bases. It 
gives warnings of reasons why some policies succeed and others fail. It can make 
connections between otherwise separate factors such as the nature of the substantive field 
and organisational patterns set up to manage them, or the power of environments over 
health outcomes. It legitimises some policies and throws legitimate doubts on others. 
Analysis of policy-making, and of research utilisation, often identifies at least three broad 
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areas of activity: policy agenda setting, policy formulation, and policy implementation [11,30]. 
Potentially, research could play a part in all three areas. Evaluation is also often seen as an 
important activity, and one that adopts a research approach. Indeed, in this paper evaluation 
is primarily being viewed as a form of research, the utilisation of which will be examined in 
the other phases of policy-making. 
 
Davies and Nutley, in a recent analysis of the role of evidence, or ‘What Works’, in a series 
of public services, suggest ‘the research community in healthcare is truly global, and the 
drive to evidence-based policy and practice is pandemic’ [31]. Of the public services, health 
care is seen as the one where, despite the difficulties, the utilisation of knowledge is most 
advanced. Although this analysis did examine a range of policy-making models, critics claim 
that the theoretical basis for evidence-based policy-making is not strong because it rests too 
much on a rational view of policy-making [32,33]. The evidence-based policy approach, it is 
stated, itself ignores the evidence about the limitations of such an approach [34]. The debate 
needs to be informed by various models of policy-making such as those set out below. 
 
Many categorisations of policy-making exist. The categorisation of policy-making presented 
here is not intended to describe the models comprehensively. Instead, it is based on 
previous analyses of public policy-making that were specifically made in the process of 
analysing research utilisation. The categorisation incorporates work undertaken by Kogan 
and Tuijnman [35], for the Organisation for Economic Co-operation and Development, and 
by many others [9,34,36-38]. The various models described are not mutually exclusive, but 
are included because each makes a specific contribution that is built on in  later analysis: 
 
1. Rational models. Rational models of policy-making assume policy-makers identify 
problems, then gather and review all the data about alternative possible solutions, and 
their consequences, and select the solution that best matches their goals. Sometimes 
this approach is known as ends-means rationality; it is thus different from some of the 
models below, which might also seem rational to the policy-makers involved. The various 
models of policy-making should be seen as a spectrum. Thus Simon [39] is sometimes 
seen as writing from the rationalist tradition, but he was critical of the more basic rational 
models and his concept of ‘bounded rationality’ involves concentrating the review of data 
on a more limited range of possible solutions. 
2. Incrementalist models. It has long been recognised that policy-making is a complex 
process. It can involve scientific knowledge and a range of other factors including 
interests, values, established positions within institutions, and personal ambitions. 
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Furthermore, evidence from research has to compete with what Lindblom and Cohen 
[40] call ‘ordinary knowledge’ which owes its origins to, ‘common sense, casual 
empiricism, or thoughtful speculation and analysis’. In models such as ‘disjointed 
incrementalism’ [41] policy-making does not involve a clear movement towards 
predetermined goals but rather is more a series of small steps in a process of ‘muddling 
through’ [42] or ‘decision accretion’ [43]. Incrementalists allow for a greater role for 
interests in policy-making debates and emphasise the many sources of information that 
impinge on policy-makers. 
3. Networks. A networks approach also highlights the role of different interests and how 
the relationships between such groups and policy-makers can result in an incremental 
policy process. The term ‘policy network’ is defined as a generic label for the different 
types of state/interest group relationships, for example ‘policy communities’ in which the 
long term relationships between government officials and representatives of leading 
interest groups are particularly powerful [44-46]. Other definitions of the term networks 
involve a wider membership and are more likely to include researchers. It is claimed that 
researcher involvement in ‘social networks’ [47] is important for research utilisation. 
Others suggest that leading experts who share a similar approach on an issue can be 
seen as an ‘epistemic community’ [48] and can influence policy. Analysis of health 
systems often suggests the influence of the medical profession over policy-making is 
particularly strong [49]. Its domination of the policy networks led to the use of the term  ‘a 
professionalised policy network’ [50,51]. Its influence is likely to be a factor in setting 
agendas and determining the type of knowledge to which most notice is taken in the 
policy debate.  
4. The ‘garbage can’ model. The ‘garbage can’ model of policy-making [52] looks at these 
issues in an idiosyncratic way. It suggests that sometimes solutions that might have 
been disgarded nevertheless remain in the policy-making system, and occasionally there 
are problems to which they become attached. Models such as this highlight the way in 
which policy-making can be seen as a most untidy process, rather than neatly going 
through a series of phases [53]. 
 
These various models of policy-making, even occasionally the final one, are likely to be 
found relevant to different circumstances and parts of health systems. They will have 
different implications for the utilisation of research and although they do not stack up as 
connected paradigms, or have much predictive power, they help put shape onto otherwise 
inchoate patterns. We shall explore how far they specifically map on to models of research 
utilisation after considering the range of overlapping categorisations of health research. 
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2.2 Categories of Health Research and Possible Levels of Utilisation 
The categorisation of health research discussed here has a potential importance for the 
analysis of utilisation. Often a broad distinction is made between basic, clinical and applied 
research. By its nature basic, or blue-skies, research is not often likely to be utilised until 
further, less basic, research has been undertaken and perhaps some synthesis with other 
findings has occurred. Research that follows priorities determined by the researchers 
themselves, according to the ‘internalist’ norms of science [54], is more often, though not 
always, going to be basic. Applied research is more likely than basic research to be following 
an agenda driven by forces other than the scientific imperative. Just because the research 
topic has been set by non-researchers does not, of course, ensure its impact. Nevertheless, 
where such drivers and sponsors are also the most likely potential users of the research, this 
provides some of the circumstances that might encourage utilisation [7,53,55]. 
 
There is generally greater resistance within health services to the use of social science, 
despite it often being applied and user-driven, than there is to the adoption of the findings 
from natural sciences [7,10] such as those used in clinical science. Possible explanations 
include the fact that the more highly technical and specific the research, the more there 
might be circumstances in which it can be utilised directly by policy makers without 
ideological or political considerations intervening too much. Moreover, the receptors of 
research are likely to place more confidence in the strictly controlled natural sciences than in 
the more eclectic social sciences. Much of policy-making can be seen as a craft, which 
draws substantially on ordinary knowledge and in which the contextual component will often 
be more significant than the type of evidence offered by social science research [56]. 
 
Another partially overlapping distinction is between national and international research. 
International research findings might be more likely to be utilised where there is greater 
technical content in the research and also potential for application to an issue of patient care. 
The report of the Commission on Health Research for Development also identified the 
particular contributions that national and global health research could make [26]. It 
developed the concept of Essential National Health Research (ENHR). This entails a 
strategy in which each country plans its health research according to country-specific health 
problems and the contribution it can make to regional and global health research. 
Mechanisms for the synthesis or systematic review of research might become even more 
important in relation to international research. 
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Adding to the epistemological debate about the most appropriate forms of production of 
knowledge intended for utilisation, Trist [57] argued that domain-based research represented 
a third category alongside basic and applied research. Domain-based, or policy-oriented, 
research is essentially interdisciplinary and the crossing of new boundaries and the creation 
of new syntheses may advance both knowledge and human betterment. It also entails wider 
reference groups, beyond the scientific or clinical communities. Along similar lines, Gibbons 
et al [58] claim to identify a shift from the traditional discipline-centred mode of knowledge 
production that they characterise as Mode 1, towards a broader conception of knowledge 
production described as Mode 2. In this, knowledge is generated in a context of application 
and addresses problems identified through continual negotiation between actors from a 
variety of settings. The results are communicated to those who have participated in their 
production. Although the degree of change described by Gibbons et al could be exaggerated 
[59], this general approach, as with that of Trist, is compatible with attempts to increase 
utilisation by focusing research production on the interests of at least some potential users. 
 
A slightly different dimension, but one also associated with utilisation, is that of the features 
of specific research studies. When a particular piece of research is seen to be of high quality 
this might help reinforce a policy-maker’s inclination to use it [14,60], as might a favourable 
view about the quality of the specific researcher [10]. The argument, as developed by Weiss 
and Bucuvalas, is that where the policies are potentially controversial the decision-makers 
will not want the credibility of their case undermined by critics pointing to flaws in the 
research behind the policy [60]. When Ministers in the UK supported actions to address 
gender inequalities in the medical profession, they did so with full confidence in the quality of 
the research that demonstrated the problem [61]. Examinations of the use of economic 
evaluations and Health Technology Assessments (HTAs) in policy-making have considered 
the importance of the quality, reliability, timeliness and comprehensiveness of research in 
influencing the level of utilisation [62-67]. For example, the latter two factors were highlighted 
as important determinants of the usefulness of the information in the context of drug 
formulary decisions in the USA [68]. 
 
Different types of research are likely to be most relevant for various levels and situations of 
policy-making, and for different aspects of those policies. There is no agreed typology of 
policy categories suitable for utilisation assessment [11]. Above, we suggest that the 
interpretation of policy being adopted here covers national policies, local health service 
policies and policies made by professional bodies. Along not dissimilar lines Black [33] 
argues that an earlier threefold categorisation [69] could be appropriate when examining 
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health research and policy-making. The three categories are: governance policies which 
relate to organisational and financial structures; service policies which cover resource 
allocation issues and pattern of services; and practice policies which relate to the use of 
resources by practitioners in delivering patient care. A similar division appears in the 
threefold categorisation proposed by Lomas: ‘legislative, administrative and clinical’ [70]. 
Legislative policies relate to the overall framework for organising health services; 
administrative to the running of the service and allocation of resources within the overall 
framework; and clinical to the policies about what therapies are applied. These 
categorisations are best seen as a spectrum, but it is generally agreed that research has 
least impact on the first of these categories and most on the third where often the relevant 
knowledge comes from clinical research. This is despite the frequent delays in turning 
research evidence into improved patient care [71,72]. 
 
Some of the issues in this section are illustrated in relation to Health Technology 
Assessments (HTAs). Various features of HTAs might be associated with the sometimes 
quite high levels of translation into policy-making and through into the final outcomes [14,73-
75]. Many HTAs are undertaken, commissioned, or produced by technology ‘sponsors’ 
specifically for agencies set up to advise governmental bodies setting policies for delivering 
patient care in national health systems. Frequently they address a very specific question that 
has been identified and prioritised by the health care system: presumably, a question to 
which the system wants an answer, and by implication is willing and able to accept 
alternative outcomes if they can be supported by evidence. 
 
Whilst these HTAs are ‘technical’ in the sense that they typically relate to quantitative 
measures of effectiveness and cost-effectiveness of specific interventions, they do have 
important distributional and equity implications. Policies deriving from them may induce 
strong public and patient reactions (as is evident in media coverage of proposed guidance 
from bodies such as The National Institute for Clinical Excellence in the UK). This 
emphasises the need in such systems to differentiate between the research activity of health 
technology assessment and the decision-making (or guidance forming) process of appraisal 
of that evidence and its implications [76]. 
But even for HTA the evidence of widespread, direct impact on policy (with policy seen as 
entirely convergent with the research evidence) is at best patchy. A study in the Netherlands 
by van den Heuvel, et al [77] concludes that policy decisions concerning the introduction of  
(new) technologies in health care are not based on the results of medical technology 
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assessments. Rather, 'political arguments and interest groups decide the outcomes’. In a 
recent literature review, Barbieri and Drummond [78] found few examples of HTA impact in 
European health care systems. At the local level, those involved in making policies about the 
introduction of new medical technologies are likely to view the contribution that effectiveness 
research can make in different ways, depending on their professional backgrounds [79]. This 
discussion underlines the fact that even in the circumstances most favourable for ‘rational’ 
policy-making there are limitations upon it. This indicates the need to consider the full range 
of models of research utilisation. 
 
2.3  Models of Research Utilisation 
Having reviewed various models of policy-making in the first section of this chapter, and 
examined different types of research in the second section, it will now be useful to consider 
models of research utilisation in policy-making. Then we can see how far the various strands 
in the chapter can be drawn together and developed. We start by looking at previous models 
of research utilisation, and then suggest ways in which they could be elaborated.  
Following the work of Weiss [19,80], and others [7,14,37,38,55,81,82], various models of 
research utilisation in policy-making have been identified, and they are thought to be 
applicable beyond the social sciences: 
1. The classic/purist/knowledge-driven model. This suggests a linear sequence in which 
research generates knowledge that impels action. 
2. The problem-solving/engineering/policy-driven model. This also follows a linear 
sequence, but begins with the identification of a problem by a customer who requests the 
researcher to identify and assess alternative solutions. This was explicitly the model 
behind the changes attempted by the UK Department of Health in the 1970s [7]. 
3. The interactive/social interaction model. The process here is a set of interactions 
between researchers and users rather than a linear move from research to decisions. It 
ensures they are exposed to each other’s worlds and needs. 
4. The enlightenment/percolation/limestone model. According to this, research is more 
likely to be used through the gradual ‘sedimentation’ of insight, theories, concepts and 
perspectives. This model has the advantage of extending the range of ways in which 
research is seen to be utilised.  
5. The political model. In this, research findings become ammunition in an adversarial 
system of policy making. 
6. The tactical model. Here research is used when there is pressure for action to be taken 
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on an issue, and policy-makers respond by announcing that they have commissioned a 
research study on the matter. Whilst this can sometimes be seen as a cynical delaying 
tactic, there are other occasions on which the commissioning of research provides the 
political system with a valuable breathing space, thus reducing the chances of irrational 
policy-making. 
 
There is no precise overlap between the principal characteristics of policy-making models 
discussed earlier and the utilisation processes listed above such as would allow them to be 
presented in neat pairs of singletons. The first two categories of utilisation both fit with 
rational models of policy-making, but it is the problem-solving model that shares the same 
starting point: identification of a problem by a policy-maker. The more incremental models of 
policy-making have the longer time frame implied by interactive and enlightenment models of 
utilisation, but sometimes these forms of utilisation lead to paradigm shifts which are much 
more radical than is inherent in incrementalism.  
 
Policy networks are seen as providing a useful framework for studying research utilisation 
[36]. Where researchers become part of a policy network, or find their ideas taken up by 
elements within it, this could be a strong version of the interactive model and be an important 
route for such findings to enter the policy arena. Network approaches can highlight the role 
of stakeholders in research utilisation [9,14]. (The network concepts could also, however, 
help to explain the difficulties some research faces in gaining acceptance, or even a hearing. 
Policy-making systems can be relatively impermeable to research findings that are contrary 
to the consensus developed as a result of the strong, long-term, links between departmental 
officials and leaders of the main interest groups).  
 
It is of value to explore the variety of policy-making/utilisation connections because they 
underline the argument that it is not realistic to expect policy-making always to follow the 
ends-means rational model that might entail the clearest use of research. Weiss also 
suggests that there are three main forms in which research might appear and be utilised in 
policy-making: as data and findings; as ideas and criticism in the enlightenment mode; or as 
briefs and arguments for action [83]. Along similar lines the utilisation of research in policy-
making is sometimes considered to be instrumental, conceptual or symbolic [11]. As we 
have seen, instrumental use involves research findings being directly used in policy 
formulation, conceptual use refers to a type of enlightenment mode of utilisation, and 
symbolic to the use of the research to support a position already taken, which may be to 
continue with existing policies. 
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 Taking another of Weiss’s arguments, that utilisation of research can be usefully be defined 
as a process of interaction between research inputs and decision outputs [43], we next 
elaborate the range of possible uses of research. Given the diversity of forms of knowledge 
and policy decision, their interaction has to be understood in the context of both the diverse 
values shaped by philosophies of knowledge and the practical aspects of policy-making. 
With regard to the former, policy-makers may privilege empirical findings against more 
abstract and general models of reality. In terms of policy-making it is useful to distinguish 
three dimensions: the nature of decisions, that is, the extent to which they are explicit and 
specific versus implicit and diffuse; the extent of choice available in a given situation; and the 
political or technical character of actors participating in decisions. These are shown on 
Figure 2 and developed below but it is useful to consider the categories as a spectrum. 
 
Figure 2: Decision Context, Research Inputs and Forms of Research Utilisation in 
Policy-Making  
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Sometimes policy-makers make rational and weighted decisions along a well charted course 
of action, yet more often apply knowledge through largely routine or unconscious processes 
in response to ad hoc situations; here the context is implicit rather than explicit. A situation of 
choice will exist when several alternatives are perceived as viable, contrasting with a 
situation where a decision has been taken and the role for research is rather to support this 
choice. Support in turn covers two types of situation. Specific findings can be used to 
legitimate decisions when these have been formed, have hardened or when they are being 
implemented. In relation to the concept of models referred to above, support is more a 
matter of explicit policies being seen to be made by institutions that are research-based and 
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therefore the policies gaining greater credibility. Political decisions are normally justified in 
terms of social values and understandings shaped in the political arena, but there can be a 
role for scientific inputs in the policy formulation. Technical decisions are those that are 
expected to be justified in terms of scientific or specialised methods.  
The combination of diverse forms of scientific inputs and decision outputs shapes the 
processes of utilisation and creates specific expectations and opportunities. The 
components of Figure 2 are expounded in more detail as follows: 
Conceptual modelling. Knowledge to inform complex situations is frequently demanded in 
the form of concepts to model or shape the general nature of the policy problems and 
possible solutions. Planning health sector reforms or identifying health policy in areas 
normally outside its purview, such as poverty or economic development, are likely to 
demand such knowledge, as they provide new disciplinary or social perspectives on a given 
problem and activate new associations and meanings for policy issues [84]. They can be a 
first step to other forms of research utilisation. 
Data-based policy. This form of utilisation aims to influence courses of action on the basis 
of the strength of empirical findings. Scientists may take the lead through a ‘knowledge-
driven’ approach, or policy-makers can demand such knowledge to solve specific problems 
(‘policy-driven’ model). In either case scientific rigour, robustness and objectivity would be 
principles trusted by both researchers and policy-makers. 
Constrained modelling. Constrained political conditions give rise to utilisation that, from the 
perspective of researchers, uses only a restricted range of available knowledge. Likewise, 
policy-makers will not commission or will discourage research that, in its broad outlines, 
poses more political risks than benefits [85]. 
Strategic research. Policy is most often formulated in a context where lay (as opposed to 
technocratic) actors vie for power and resources. The choice of policy may be open, but only 
through politically controlled windows of opportunity. Under these circumstances the ultimate 
validity of research will be assessed together with other and often competing evidence. The 
aim of researchers is usually to influence policy choice or to make explicit the costs of not 
adopting a recommended course of action [86]. 
Symbolic payback. Science has become a potent cultural symbol that permeates modern 
life and confers privileges on its users. Likewise, there is a political pay-off in supporting 
research and building research capacity in strategic areas. Research has become ‘an 
essential mode of communication and persuasion in the public arena’ [43]. In complex 
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organisations, research could be a common language used to talk across the boundaries of 
interests and content areas given its capacity to effectively link disparate realities and 
because of ‘the patina of rigor that science confers to discourse’. This might suggest that 
policies from bodies known to be research-informed might be more likely to be supported. 
Symbolic argumentation. Policy making may be based mainly on reasons of interest, 
ideology or intellect. Under these circumstances, however, research can still be used as 
ammunition to support the decisions made and being implemented. Science content is here 
used as a collection of arguments, rather than as data or evidence to be weighed. 
Arguments may be fashioned as by-products of formal research publications, particularly by 
policy analysis units, consulting firms and the media [87]. 
Paradigms. Given the large measure of unconscious elements in every-day decision 
making, accepted ways of interpreting reality and facing problems are the most important 
influence. An aggregate of  normative expectations may amount to an overriding view of  
what is desirable health policy, such as those advanced in Welfare State thinking. Such 
policy paradigms may be triggered off or supported by single or grouped assumptions 
derived from research, which also may achieve paradigmal status. Individual policies are 
likely to reflect the dominant paradigms of their time. 
Policy-Makers’ Practice Wisdom. How far individual policy-makers will automatically 
attempt to use research findings on a regular basis will depend on multiple influences, such 
as training, continuous education, exposure to the media and to the demand of clients. 
 
Although these categories are not water–tight, they help indicate the breadth of types of 
research utilisation and, therefore, areas on which any assessment methods should focus. 
Our review of previous work will provide examples of where wide interpretations of utilisation 
have been incorporated into studies of the impact of research.  
 
Various elements from this chapter will be particularly useful as we develop our own 
conceptual framework for analysing and assessing research utilisation in the context of the 
increasing attention on HRSs. For example, the importance, but also the limitations, of the 
problem-solving model must be considered when examining the role of research priority 
setting. Furthermore, in light of the practical limitations on rational models, the importance of 
interactive perspectives will be highlighted as a way of encouraging policy-makers to be 
responsive to relevant research. Overall, both these points, and others, suggest that it is 
appropriate to focus on the actions that could be taken to encourage permeability at the 
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interfaces between policy-makers and researchers. Such actions should help ensure both 
that researchers are aware of policy-makers’ needs, and that the policy-making system is 
willing and able to absorb relevant research findings.  
  
It is also possible to link some of the ideas in this final section to the three phases of policy-
making referred to earlier in the chapter: agenda setting; policy formulation; and policy 
implementation. For agenda setting the research could impact in one of several ways. 
Research could demonstrate the existence or extent of a problem, through either specific 
findings or a process of enlightenment. Alternatively, it could be that, as in the knowledge-
driven model, the mere generation of the findings leads to pressure to act upon the new 
knowledge. The use of research in policy formulation could be in either the instrumental or 
conceptual/enlightenment mode. A further possibility is that it could be used as briefs to 
inform arguments as set out in the political model of research use. The implementation of 
health policies is widely acknowledged often to be difficult [37,53]. At the implementation 
stage, research could play some part in demonstrating the best way to implement policy and 
could inform decisions. It could also be of symbolic use in helping to build support for 
implementation through assistance with communicating or justifying the policy and being 
used to generate support for it in terms of financial resources, political commitment, and 
public opinion. 
 
Before developing the material from this chapter into a conceptual framework and methods 
for assessment of utilisation, it will be useful to review the focus and methods adopted in 
previous studies of policy-making.  
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CHAPTER 3: EXAMPLES FROM PREVIOUS STUDIES 
 
3.1 Analysing Policy-Making 
Studies of the nature and impacts of policy-making can each exploit a wide range of analytic 
methods. The area covered by them is extensive and here we review one study: that of 
policy change in relation to health financing reforms in South Africa and Zambia [30]. It 
illustrates several of the approaches that can be applied when analysing policy-making in 
general, and is included here as a backdrop to the accounts, immediately following this one, 
specifically on research utilisation in policy-making. The case study in each country was 
organised according to a conceptual framework consisting of a process of policy change 
moving from, Gilson et al state, ‘agenda setting around a reform of focus, to reform design, 
and then through implementation to the achievement of immediate and longer term changes’ 
[30]. The policy analysis approach of Walt [37,88] was also drawn upon so that the factors 
influencing each stage of the reform process were categorised and analysed according to 
four broad factors: context, actors, process and content.  
 
In the two countries data were collected through: documentary analysis; key informant 
interviews with policy-makers and analysts; media analysis; and review of secondary 
sources. The data analysis techniques included: development of a timeline for each reform; 
stakeholder analysis; policy mapping techniques; impact analysis through use of secondary 
data; and a review process. The two case studies incorporated examination of the impact on 
the policy development made by research analysts, both inside and outside government, 
and found it to be ‘strongly dependent upon the presence of a policy champion’ [30]. 
 
3.2 Contributions from Selected Previous Studies of Knowledge Utilisation in Health 
Policy-Making 
This section draws selectively upon a review of a wide range of previous studies of research 
utilisation in health policy. From this several key themes are discussed:  
• focus of the study; 
• how far the study was based around a conceptual framework and how far comparisons 
or conclusions were drawn; 
• methods and standardised measures used in assessing impacts and outcomes; 
• levels of utilisation and other benefits shown. 
 
Focus of the Study. Studies that start with the research project or programme, and 
examine the impact that it has had [14,17,75,89,90], have the advantage of a reasonably 
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tightly defined focus. They can be of use for research funders, but often run into the problem 
that any impact research makes is usually of a contributive nature and it is difficult to identify 
the impact of one project or programme from that of others with which the findings get mixed 
[16]. Other studies consider the portfolio of researchers’ work over a particular period [91], or 
the contribution of specific health research centres [29,92-95]. Studies such as these lend 
themselves to network analysis. 
 
Health policy-makers have been the focus of studies. Some examine the policy-makers’ use 
of research in general [96]. Others can involve health policy-makers, for example in mental 
health, being shown research papers describing evaluations of programmes and then asked 
how useful they would find such research [60]. Drummond et al asked local policy-makers 
about their attitude to using economic evaluations in general, and whether they had used 
specific evaluations [65]. A major way in which impact on policy has been assessed is 
through studies that start with a policy area, or theme, and then seek to identify how far the 
policy-making or implementation has been informed by research [11,77,96-102]. Focusing 
on the policy area has the advantage of facilitating some assessment of how far lack of 
relevant research is the problem, as opposed to the underutilisation of existing research.  
 
The two broad approaches, starting with research or starting with policy, have elements of 
overlap. A study of the role of research in the regulation of private health care providers in an 
Indian state focused on the activities of a key research centre [103]. In some studies of the 
impact of research on particular health care programmes, interviews with researchers 
produce examples of how their own research has been utilised [10,104] 
 
Some studies have cases from a range of countries and have been organised by, or 
involved, international bodies including the Council on Health Research for Development 
(COHRED) [5], the European Union (EU) [101], and the Cochrane Collaboration [102]. Other 
studies explicitly take examples from two or more sub-national units [11]. Many studies cover 
a series of examples from the same country or sub-national unit. 
  
Conceptual Framework and Comparisons. Some of the most illuminating studies are 
organised according to a conceptual framework. Thus Landry et al [91] attempted to 
operationalise Knott and Wildavsky’s Ladder of Knowledge Utilisation which suggests there 
are six stages of utilisation [104]. These are: transmission, cognition, reference, effort, 
influence, and application. Generally, studies that adopt a conceptual framework involve a 
series of cases.  Buxton and Hanney [14,17,29,106] organised several series of studies 
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around the conceptual framework described in Figure 1. Walt’s framework for analysing 
health policy-making [88], described earlier, was used to organise impact studies in Mexico 
[10]. The EU-funded set of studies in developing and developed countries [101] was based 
around a conceptual framework, as described by Sauerborn et al [9], that concentrates on 
analysis of the role of the various interests or stakeholders.  
 
A key feature of all these studies is that the conceptual framework facilitates comparable 
analysis of the results. A considerable amount of this analysis is drawn upon elsewhere in 
this paper, but one example is given here. Lessons were learnt from the EU-funded studies 
regarding: factors enhancing or hindering research use; possible indicators to measure 
research use; and possible strategies to increase such use. However, it has become clear 
that making generalisations is difficult because of country specific factors such as differing 
contexts (including the political system and culture), differing stakeholder constellations, and 
differing availability and quality of research. A conclusion, therefore, is that careful 
consideration of these factors, rather than recipe-like approaches, will be needed for 
successful enhancement of the use of research. (A. Gerhardus-personal communication). 
Similarly, Berridge and Stanton [107], after reviewing various case studies that were not 
undertaken as part of a set, identify a series of factors considered important in the 
research/policy relationship. They go on, however, to note that ‘they are necessarily 
historically determined, and culture and context specific, rather than part of a reproducible 
general formula for action’ [107].  
 
There are clear tensions in our analysis between recognition of the genuine limitations in the 
ability to make generalisations and a desire to learn as much as possible from comparisons. 
It is useful, therefore, to note the findings from a study that addresses the issue of how far 
analysis from developed countries might be appropriate elsewhere. Trostle et al found there 
were various issues where, in comparison with developed countries, there could be different 
emphases in Mexico and ‘in other developing country contexts’ [10]. Nevertheless, most of 
the factors that Husén and Kogan [108] had identified as encouraging utilisation of 
educational research in industrialised nations were, they state, ‘also found to be important in 
our study. These included decision-makers’ willingness to consider research results as input 
for  decision–making, and political stability...and the existence of research networks or 
commissions which provide a favourable arena for interaction between research and 
decision-making’ [10]. 
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Methods and Standardised Measures used in Assessing Impacts and Outcomes. The 
two methods used most frequently, and usually used together, come from the qualitative 
tradition: documentary analysis and in-depth interviews [10,11,14,63,75,77,97,98,104]. The 
need for having the flexibility interviewing can provide is well illustrated by studies in which 
the original interview schedule had to be amended to take account of the different 
perspectives held by policy-makers of the role of research [79]. Interviewing is useful for 
understanding many aspects of research utilisation, including tracing networks between 
researchers and users [90]. 
 
Some studies use insider knowledge [94,102] and there has been some adoption of 
questionnaires to researchers about the utilisation of their work [11,106]. Particularly where 
the policy-making is at a local level, questionnaires have been used and administered either 
by phone [68] or by post [65]. In the latter case, Drummond et al also attempted to assess 
the problem of inaccurate responses. They included two fictitious studies in the list sent to 
policy-makers, and almost 20% claimed to have seen these studies; some of those admitted 
to having been influenced by them [65]. Bibliometric analysis is sometimes incorporated into 
broader studies [106] and, in an analysis of the papers that were cited in clinical guidelines, 
Grant et al specifically adopted a bibliometric approach [109]. Historical approaches have 
also been adopted [99,107] and allow a more contextualised analysis. The methods used 
are diverse, and only partially depend on the focus and purpose of the studies. The list of 
studies described here partially overlaps with, but is not identical to, those 24 included in the 
recent systematic review [22]. The 24 include a greater proportion that use questionnaires 
administered either by phone or post, but still face-to-face interviews form the majority. 
 
There have been a few recent attempts to scale or score the degree of impact. Four such 
studies are described below, starting with two where the focus of each case study was a 
specific piece of research. An assessment of the impact of HTAs in Quebec used a case 
study approach [75]. Initially seven levels of critical incidents were identified. The impact of 
each HTA was scored on the basis of documentary analysis, and the information completed 
and validated through contact with key witnesses. In this way, Jacob and McGregor explain, 
‘by taking into consideration the level and number of critical incidents, an overall estimate of 
impact on policy was awarded to each HTA. This was reported in a scale extending from 0 
(no impact) to +++(major impact). The weight awarded to critical incidents was adjusted 
according the nature of the decision at issue’ [75]. 
 
 
 
 
 
 
 
21 
 
Despite the largely, though not exclusively, qualitative methods used by Buxton and Hanney, 
in one study they attempted to score the impact made by projects on the basis of material 
from questionnaires [106]. This was partially validated by re-scoring those projects for which 
more detailed information became available from case studies. The correlation was quite 
good at an overall level, though there were differences in both directions at the individual 
project level. This scoring was entirely a methodological exercise and the results for specific 
projects were not identified. 
 
Lavis et al coded their interview material according to whether the research had been used 
at agenda setting and/or policy formulation stages, and whether the research had impacted 
on all the policy or only partially [11]. 
 
The above three examples involved members of the assessment team undertaking the 
scoring and coding. The EU- funded project described by Gerhardus et al developed a 
model for mapping research to policy flows based on the qualitative case studies. From this 
model a set of numerical indicators was devised which entailed scoring by both the 
assessment team and stakeholders [101]. The intention, in what is probably the most 
methodologically ambitious research utilisation study included in this review, was that the 
indicators would be used in each of the eight countries to facilitate comparisons between 
research utilisation before and after interventions aimed at increasing such utilisation. In 
each country a policy was identified along with the content, conclusions and 
recommendations of the relevant research. Next, a series of questions was put to the 
stakeholders and points allocated according to their recall of the content etc. Further points 
were allocated depending on the references to the research made in speeches, statements, 
guidelines and similar sources. Finally, the stakeholders were asked to rate on a five-point 
scale a range of factors, including research, that influenced their decision making [101]. 
 
Preliminary results from the study suggest that conceptually the set of indicators has proven 
to be helpful, but problems with computation of the indicators arose due to the generally 
small sample of stakeholders interviewed. There were also problems related to the data 
collection for applying the knowledge-related indicators. This part of the stakeholder 
interviewing frequently created a possibly stressful, or even embarrassing, exam-like 
situation and in some cases revealed problems due to the considerable recall period 
involved when probing about older pieces of research.  The body of indicators developed in 
the project was quite large, and it is considered appropriate to reduce it to a simplified set of 
core indicators (U. Sunderbrink -- personal communication). 
 
 
 
 
 
 
22 
 
Level of Utilisation and Final Outcomes. The examples suggest a greater level of 
utilisation and final outcomes in terms of health, health equity and social and economic gain 
than is often assumed, whilst still showing much underutilisation. There is considerable 
variation, both within and between studies. The study of the role of research in child health 
policy and programmes in Pakistan [104] found some examples of immediate clear-cut 
linkage between research and decisions, but in general the view was that research was little 
utilised. A mixed picture was reported in the Mexican studies: biomedical or clinical research 
was thought to be ‘a critical resource for decision–making in each of the four programmes’, 
but the importance of other types of research varied [10]. Of the eight policies examined in 
two Canadian provinces, four seemed to have been influenced by research, for example, in 
terms of agenda setting, research identified the need for increased pneumococcal 
immunisation in Saskatchewan [11]. Research utilisation is also demonstrated in some of the 
primarily insider-accounts, including that by Phoolcharoen [94] describing the role of the 
Health Systems Research Institute in Thailand in enabling research to impact on the reform 
of the health system. 
 
Considerable utilisation is reported in some of the studies that focus on specific pieces of 
research. For two of these sets of studies, a wide interpretation of utilisation in policy-making 
was used [14,17,89,106], and one focused explicitly on evaluative research [89]. In some, 
but not all, such cases there was purposive selection. The study of the HTAs in Quebec 
showed over 85% had had an impact on policy [75]. The latter study is also one of the 
comparatively few to trace through from impact on policy to actual outcomes or benefits. It 
was suggested there had been cost savings of between $16 and $27 million annually. The 
Buxton and Hanney studies also attempted to trace through to the outcomes although this 
proved difficult. In one case, the evidence suggested that the research had strongly 
influenced the policy on heart transplantations. Buxton was able to estimate the increased 
number of QALYs (Quality-Adjusted Life Years) that resulted from the programme being 
properly funded and organised, as opposed to the counterfactual which might have been a 
less substantial and piece-meal development of heart transplantation in the UK [110]. 
 
While not specifically measuring levels of benefits, some of the studies have clearly shown 
an improvement in health equity as a result of policy changes: ‘research has also played an 
important role in the expansion of Medicaid to poor pregnant women, young children, the 
elderly, and disabled’ [111]. Other studies have not only demonstrated a major impact on 
policy but also been able to describe how research led to a paradigm shift [95].  
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CHAPTER 4: KEY ISSUES IN THE ANALYSIS OF RESEARCH UTILISATION IN POLICY-
MAKING 
 
4.1 The Role of Interfaces Between Researchers and Policy-Makers 
Increasing attention is focusing on the concept of interfaces between researchers and the 
users of research [6,7,14,29,93,112]. This incorporates the idea that there are likely to be 
different values and interests between the two communities [113], with their different time-
frames [6,7], and that research is less likely to be utilised in a significant way unless 
networks and mechanisms are established at the interfaces. One version of the interfaces 
concept is presented in Figure 1. The ‘permeability of the interfaces’ [14] becomes important 
given the potential problems in the transmission of views and findings between researchers 
and   policy-makers. Issues around interfaces need to be considered at various stages 
including priority setting, commissioning of research and communication of the findings.  
 
The power relationship between publicly funded researchers and policy-makers may be 
described in terms of an exchange relationship [114]. The policy-maker receives new 
knowledge, and the testing of existing knowledge, in return for providing resources and 
public legitimacy. If the exchange becomes imbalanced, a reduction in the value of its 
outcomes becomes likely. Some of the analysis below attempts to identify both ways of 
enhancing the exchange, and the items upon which any assessment of utilisation should 
focus.  
 
As shown in Figure 1, however, the picture is broader than this because many of the 
research findings flow into the pool of knowledge. Furthermore, some research that is 
potentially of use to policy-makers will not have been funded by them. This includes 
research from the international stock, which highlights the role of research as a global public 
good [3]. If a national system is to draw on this to maximum benefit, various interface 
mechanisms might be needed. We start, however, with a mechanism specifically related to 
user-driven research.  
 
4.2 Action at the Interfaces Between the Health Research System and Policy-Makers to 
Enhance Impact: Priority Setting and Research Commissioning 
It is not necessary here to describe all the expert approaches to research priority setting--
see The 10/90 Report on Health Research, 2001-2002 [4] for a recent review. Given all the 
current activities, however, it is important to consider problems identified in previous 
attempts to enhance utilisation through priority setting [7]. Resistance to priority setting 
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comes from those who adopt the ‘internalist’ view of research. They share Polanyi’s opinion 
that the best science comes from the freedom of the researcher to pursue the priorities that 
emerge from the scientific imperatives [115]. Most now accept the contention, as voiced by 
Kogan and Henkel, that if health research is ‘internalist and freely sponsored, the problem 
for government will be that of securing adequate brokerage with it...because it has not taken 
part in the setting of problems’ [7]. 
  
In addition to the technical questions to do with how best to identify the most important 
priorities in terms of health needs, the utilisation aspects of the debate perhaps revolve 
around two key questions: 
• are priorities being set that will produce research that policy-makers and others will want 
to use? 
• are priorities being set that will engage the interests and commitment of the research 
community? 
 
Research that Policy-makers will be more likely to use. Policy-makers have not always 
found it easy to identify their needs or to aggregate the demands from various sources [7]. 
Again, the limitations on the ends-means model of rationality must be recognised and it 
should not be assumed that sophisticated priority setting mechanisms will automatically 
produce research regarded as relevant by policy-makers. This is why it is so important that 
the methods described do incorporate stakeholder involvement and an iterative approach 
[4], and that, particularly when overseas agencies/researchers are involved, efforts are made 
to link the research to the priorities of the national policy-makers [21]. This should boost local 
ownership of the research. From the perspective of the policy-maker it is important that the 
research not only seems relevant, but also timely. Involvement in such priority setting is itself 
sometimes seen as a way of informing policy [7]. Any assessment of utilisation should 
include identification of policy-makers’ attitudes towards the priorities set. 
 
The ability of policy-makers to set priorities, and the likelihood of them using the eventual 
research findings, will probably be increased if they are able to develop long-term links with 
researchers. This is especially the case for researchers in centres where they can build up 
their own shared reservoir of knowledge on the key issues and discuss this with policy-
makers [14,29,103]. In these circumstances, researchers help develop the policy-makers’ 
views about what are the important issues that should be addressed by research. Crucially, 
this allows researchers to play an interactive role in shaping policy-makers perceived needs. 
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Priorities to Engage the Commitment of Researchers. There is a danger that the more 
the agenda is set unilaterally by non-researchers, the less the research community will be 
committed to working on it. At the commissioning interface between priority setting and the 
funding of specific pieces of research, there is some scope for subtle defection from the 
agreed priorities [116]. It is possible that the move towards Mode 2 research [58] means that 
an increasing number of researchers are moving away from belief in the superiority of the 
internalist Mode 1 approach. Where the policy-makers are working with the researchers as 
suggested by Trist [57] and Gibbons et al [58] this could result in research that has more 
chance of being utilised, but much of Gibbons et al’s analysis is not related to formal priority 
setting exercises. Iterative research commissioning processes [33,117] and priority setting 
[4] might be ways of addressing both problems identified in this section.  
 
Finally, despite the importance of priority setting, there is no monopoly of wisdom and those 
who wield the enormous power of government do well to foster their own critics and counter-
analysis [7]. Independent research can provide critical commentaries and alternative 
perspectives that are important for healthy policy-making in the long term.  
 
4.3 Action at the Interfaces Between the Health Research System and Policy-Makers to 
Enhance Impact: Transfer of Research to Policy-Makers 
Much previous work stresses the importance of interactions between policy-makers and 
researchers in increasing the likelihood of attention being given to the knowledge produced. 
This continues the above discussion and fits especially well with Weiss’s interactive model 
[19], and with the view that policy-makers are unlikely to take much notice of research if the 
first they know about it is when it arrives on their desk [89]. It is claimed that previous 
interaction increases the possibilities of the findings moving up the Ladder of Research 
Utilisation [105], and that the building of bridges between researchers and policy-makers is 
important and could be achieved by ‘decision-linked research’ [6,118]. 
 
The studies described earlier provide many examples to support this analysis, including 
discussion of ‘linkage strategies’ [104], and ‘interactions’ [11].  A cholera researcher is 
quoted in the Mexican study as saying: ‘ “if there isn’t a good relationship between a 
researcher and a decision-maker...it is difficult for research results to be taken into account” ’ 
[10]. Buxton’s insider account of his own work evaluating the emerging UK heart 
transplantation programme illustrates the benefits that can come from close liaison with the 
potential users [110,119]. As a result of frequent liaison the Department of Health knew the 
likely results of the final report. Then, on the day it was received, a major decision was made 
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to fund a full heart transplantation programme in the UK, the benefits of which were 
described earlier. This demonstrates that although building interactive relationships is often a 
long-term endeavour, it can result in rapid policy-making.  
 
Some of the studies provide examples of how good interaction was achieved through 
informal communications as a result of deliberate actions by researchers or even through 
chance relationships [10]. Researchers themselves sometimes provide policy briefing for 
policy-makers, which is seen as a useful but underdeveloped approach [53]. The existence 
of researchers, or research responsive members, in policy networks can also be important. 
These can be international [34,120]. These types of observations are broadly supported by 
some of the three most commonly mentioned facilitators of the use of research in the 24 
studies included in the systematic review. The three are: personal contact between 
researchers and policy-makers (13/24); the timeliness and relevance of research (13/24); 
and the inclusion of a summary with clear recommendations (11/24) [22]. 
 
The various actions of individuals can be important, but it is desirable to consider the role of 
the HRS in encouraging or facilitating interactions, networks and mechanisms at a system-
wide level. Priority setting approaches are one such mechanism. The development of long-
term research centres focusing on particular topics [10,14,29] is one of the potentially 
strongest ways a HRS can take action to increase the possibilities of research being used to 
inform policy. Here the concept, noted above, of ‘epistemic communities’ [48] is useful and 
has explicitly been applied to assessments of the benefits from health research centres [29]. 
Furthermore, accounts from various countries or provinces describe the importance being 
attached to the creation of an institute for health research. Examples include: Mexico [6]; 
Thailand [94]; Canada [121] and Manitoba, Canada [93]. The desirability of such institutes 
engaging with stakeholders is being addressed by the Alliance for Health Policy and 
Systems Research [122]. Once established, such links can build on mutual respect and help 
develop an understanding of the differing perspectives. 
 
HRSs could also ensure long-standing committees or fora are formally established to allow 
scientists and policy-makers to discuss issues. These could operate at both interfaces—
feeding into the priority setting, and ensuring key policy-makers are aware of relevant 
research. Such approaches have been used in various countries including the UK [7] and 
Burkina Faso [9]. Other brokerage mechanisms that could also be provided by the HRS 
include arranging seminars for policy–makers, and funding individuals to act as research 
brokers [7;80;123], or translators [12;82]. Such individuals, who may be in key knowledge 
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management roles within the HRS, take the findings from researchers and bring them to the 
attention of policy-makers and others. It is useful to think of diffusion of the findings at 
several levels. In addition to directing findings at policy-makers within the health system, 
efforts at wider diffusion might also help build support for adoption of the findings.  
 
Whatever the direction of the dissemination, however, mechanisms are needed that review 
and synthesise research and attempt to identify the research that should be promoted from 
that that should not. HRSs have a clear responsibility in this area in terms of funding such 
reviews and their dissemination; the latter through a range of mechanisms including the 
internet. It can go further than this, however, and the attempt to provide some structure, or 
‘knowledge warehouse’ [29], to the pool or stock of knowledge should be seen as a key 
knowledge management function of the HRS. The international Cochrane Collaboration 
plays an important part in this, and was inspired by the UK Cochrane Centre that was a 
mechanism funded as part of the information system of the UK’s HRS [124,125]. The need 
to use and develop databases of evidence, and reviews of research, has been explored in 
relation to preparing evidence to inform policies on the reduction of health inequalities [126]. 
 
Many, but not necessarily all, of the mechanisms for transmission of the relevant national 
and international research are the responsibility of the HRS to provide. Some of the above 
considerations are important in the interface between national health systems and 
international research and international bodies promoting health. In drawing conclusions 
from the COHRED studies, Chunharas comments: ‘National research co-ordinating bodies, 
such as the ENHR mechanisms promoted by COHRED, can also play a mediating role to 
better foster research to policy linkages. International agencies too have an important 
contribution to make as intermediaries in linking knowledge and action’ [110]. The integration 
of research into the health care programmes of international organisations can be an 
effective mechanism for research-informed policies to be brought about [21]. 
 
4.4 The Receptor Function 
There is increased recognition of the significance of policy-makers in their role as recipients, 
or receptors, of research [7,9,11,104,112,127,128]. Despite the low response rate to their 
questionnaires, the findings from Landry et al’s study illustrate this point. They claim: ‘factors 
such as dissemination and linkage mechanisms that are generally considered to be powerful 
explanatory factors and to be the most efficient targets for policy interventions are less 
important than factors such as the receptive capacity of users when one climbs from the 
stage of transmission to the higher stages in the ladder of knowledge utilisation. Future 
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research must recognize that the same factors do not explain success at all stages of 
knowledge utilisation’  [91]. 
 
Beyer and Trice [129] also set out a series of steps policy-makers go through when using 
research and this has been applied to health research [11,62]. Epistemological, social and 
institutional issues are all relevant to the role of the research receptor [7,128]. The types of 
research relevant to policy-making vary greatly. The key questions could be seen as a 
spectrum:  
• is there research available that is either relevant to policy issues, or could help bring new 
issues onto the agenda? 
• is such research being effectively brought to the attention of policy-makers in diverse 
positions within the health system? 
• is the policy-making system capable of absorbing the research findings? 
• are there situations where the  policy-makers are willing, and able, to use it? 
 
The HRS can assist here in the various ways described, but the wider policy system has a 
responsibility to create the right institutional mechanisms and staff capacity. Broadly, the 
responsibility of the HRS is greatest in the first part of this spectrum. It is recognised that it is 
much more difficult to make recommendations about how to increase the use of research in 
the development and implementation of policy, than it is to suggest how to improve 
communications [10]. There is, however, no neat division of responsibility. The main thrust of 
our analysis is that the issues need to be addressed on a system-wide basis, and that there 
is a series of measures the HRS can take to maximise the possibilities of research 
utilisation. These include encouraging policy-makers to see the benefits in general, and in 
specific situations, of using research to help build a policy environment which will result in 
improvements in the health system. 
 
Institutional arrangements do matter [6,7]. A policy machine must face the problems involved 
in using research, some of which it will not have commissioned itself. It needs a capacity to 
decode the results of research or to discern a policy problem that might yield to disciplined 
enquiry. To some extent these needs might be met by the use of scientific or policy advisers 
from outside the policy-making body, but they may not have full access to the generative 
stage of policy development. Hence the need for internal brokerage.  These might be 
officials with either a scientific or a professional or a policy–making background.  The 
evidence is that, whatever their provenance, they may be able to assume the skills and 
value-set of boundary-crossers and research enablers [7]. Some have become famous for 
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their ability to empathise with the needs, problems and potentials of researchers whilst 
enabling policy-makers to secure otherwise inaccessible skills and knowledge [130]. 
 
The response of policy-makers to research varies not just with the type of issues and 
research being dealt with, but also with the differing attitudes they adopt towards the whole 
policy-making process [113]. As individuals, some policy-makers are much more receptive to 
research than others. The issues are wider than individual preferences, however, and also 
depend on: how far the research accords with the political and social zeitgeist of the time 
[128]; the national political and administrative culture [10]; and the institutional arrangements 
for policy-making. The historical study from Uruguay demonstrates the detrimental effect 
military dictatorship can have on research utilisation [99]. By contrast, the study from South 
Africa illustrates how, despite the problems, the new political environment can help foster the 
better use of research in the policies related to some programmes [98]. There will be clear 
opportunities for research findings to have greater impact when they are in tune with the 
wider developments of the time, but there are also dangers that such research could 
sometimes be accepted and acted upon without sufficient analysis to test its validity. 
 
There are variations in patterns of bureaucratic recruitment and other characteristics that can 
influence research utilisation. In the countries where the research and policy connections are 
strongest, the relationship has been enhanced by the fact that some of the senior 
administrators have had research experience or interests as part of their prior education 
[131,128]. This should make mutual institutionalisation of the relationship easier to secure. 
The willingness of officials to undertake policy analysis is seen as important [7]. In some 
systems specific policy analysis units [132], or think tanks of researchers [9], are established 
in health policy-making bodies. An important determinant of their success will be their 
position within the policy-making organisation. 
 
Too often, however, officials in policy-making bodies are resistant to research because they 
display strong distrust of information generated outside the organisation or system [133]. 
Furthermore, the career patterns of policy-makers are often not compatible with strong 
research utilisation if the latter depends on developing long term relations to boost 
receptivity. Given the length of many research projects, the original sponsor of research is 
often not in place when the findings are reported. Patton, the arch proponent of making 
evaluations more likely to be used through being utilisation-focused, notes that the major 
problem with his approach is the frequent turn-over of the primary intended users [134]. 
Various studies support a greater emphasis on training of policy-makers, at least those in 
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bureaucratic positions [9,10]. If such training fosters a more positive attitude towards the use 
of research findings, where relevant, in the policy-making system as a whole, this could 
mitigate some of the problems.  
 
There will be situations, particularly where the policies are likely to be made at local level, 
where there is much less likelihood that the researchers will have the opportunity to develop 
an interactive relationship with potential policy-makers. Several consequences flow from this. 
As noted previously, the characteristics of specific pieces of research can become important 
determinants of its uptake. There is an onus on the HRS to ensure it identifies and publicises 
those characteristics of research that are likely to increase its appeal to policy-makers. It 
should encourage such research to be undertaken. 
 
In some countries there are specific mechanisms that lead to the incorporation into policy 
instruments of research such as Health Technology Assessments (HTAs) and clinical trials. 
This is one of the reasons noted previously for the greater likelihood of HTAs making an 
impact. A collaborative working group examining these issues in Europe concluded that, 
whilst they were able to identify occasional examples of systematic integration of HTA in 
decision-making structures, there was no direct link between the amount of money spent on 
HTA and its impact on the decision-making process [67]. Indeed, they suggest that small 
programmes can be involved in the core of the policy-making structure whilst larger HTA 
programmes have difficulty in demonstrating impact. 
 
It seems clear that HTAs have had most impact in those situations where there are specific 
mechanisms in place that require research evidence to support well-defined policy decisions 
on provision, coverage or reimbursement (and these impact on practice where there are 
further mechanisms to ensure local adherence to national policy). The European countries 
where there is some evidence of such integration include: Germany, Spain, Switzerland, 
Sweden and, despite our earlier example, the Netherlands [67]. Conversely, HTA has had 
much less impact where these specific mechanisms are not in place and policy-makers are 
exposed to HTA only in a diffuse or indirect manner.  
 
Governments that set up what could be considered rational policy-making arrangements in 
which primacy is given to the role of research evidence might find the results face 
considerable criticisms in the media. Even with a population fully engaged in the cost 
effectiveness/rationing debate, there would still be scope for disappointed interests to 
campaign against decisions. This illustrates the desirability of an integrated approach to 
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utilisation and an awareness of all the pressures on policy-makers. 
 
4.5 The Role of Incentives 
In the context of the above discussions more attention should be given to the role of 
incentives, both for researchers to produce utilisable research [6] and for policy-makers, at 
the system or individual level, to pay attention to it. In an exercise of empirically based 
modelling, Bardach [56] assumed classical economic rationality on the part of individual 
policy-makers.  He showed how research reaches those for whom its utility exceeds the 
disutility of obtaining it and noted that co-operative relationships grow up with research 
consumers when producers try to reduce the cost to them of obtaining information.  
 
Engaging in ‘useful’ research produces some clear benefits for researchers.  It may be a 
source of satisfaction that one’s work is being taken notice of and contributing to the 
formation of policy or the improvement of practice. At present, however, it is widely thought 
that the traditional academic criteria still dominate the crucial assessments of research 
performance upon which career advancement and peer recognition depend 
[7,29,98,135,136]. The assessment of utilisation, therefore, could become a key issue if 
rewards are to focus on relevance as well as research excellence  [6,137]. 
 
4.6 The Interfaces and Receptor Model 
Any assessment of the utilisation of health research in policy-making has to integrate two 
factors: an awareness of the wider influences on policy-makers and a detailed analysis of 
the specific ways the HRS could contribute to improving the health system through providing 
the research to inform policies. An appropriate model for assessing research utilisation in 
policy-making is also likely to be one that combines both an emphasis on the importance of 
actions at the interfaces and an analysis of the role of receptors. As we have seen there are 
many models already in existence. We are proposing an interfaces and receptor model 
because it allows a range of key issues to be integrated into the analysis. These include: 
 
a) A focus on the need for multi-layered analysis. Multi-directional interactions with 
practitioners and the public are important for policy-makes and augment the crucial 
interface, for research utilisation in policy-making, between the HRS and the policy 
system. As noted above, this interface itself has various dimensions including: priority 
setting; research commissioning; and the transfer of research findings to policy-makers. 
b) An appreciation that both researchers and policy-makers have their own values and 
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interests. Therefore, for example, priority setting has to be sophisticated to maximise the 
likelihood that the research community will be engaged on a research agenda producing 
knowledge that the policy-makers will use. Similarly, just because research centres 
undertake large scale dissemination does not necessarily guarantee their research will 
be utilised [11]. Hence the importance of analysis that goes beyond examining 
dissemination and considers the nature of productive interactions and the characteristics 
of research to which receptors are responsive. 
c) An emphasis on the role of the receptor, which is necessary because ultimately it is up to 
policy-makers to make the decisions; this can be a convoluted process with many stages 
at which research could potentially have a role. Again as described above, there are 
various features of the organisation and training within the receptor (or policy-making) 
body that can enhance the utilisation of research. Even though responsibility lies with the 
receptors, the HRS should take every action possible to facilitate the use of the research. 
These are important considerations for any assessment of the success of the HRS in 
relation to utilisation. First, because they highlight the wider political context which is 
beyond the control of the HRS. Second, because they still leave room for assessments 
of the activities of the HRS, within its given context, to increase the permeability at the 
interfaces [14] and thus promote the uptake of the research findings by the receptors. 
d) An approach that facilitates analysis of the key paradox highlighted by the systematic 
review. Innvær et al concluded that, ‘two-way personal communication, the most 
common suggestion, may improve the appropriate use of research evidence, but it might 
also promote selective (inappropriate) use of research evidence’ [22]. This potential 
problem can be addressed in several ways through the interfaces and receptor model. 
First, links between researchers and policy-makers should ideally develop on a long-term 
basis so that together at the priority setting interface they produce a research agenda 
that reflects some synthesis between the needs of policy-makers and the perspectives of 
independent research analysis. Second, the interfaces and receptor model emphasises 
the importance of the role of organisational and training issues such as the need for 
capacity to undertake systematic reviews and policy analysis within any system. While 
such capacity is seen as a way of enhancing the ability of the receptors to absorb 
research, it should also allow proper analysis of all evidence to be undertaken. 
 
There could, therefore, be value in having assessments of utilisation that integrate the 
modelling of research utilisation with the epistemological, social and institutional analysis [7] 
inherent in concepts such as interfaces and receptor functions. This might contribute to 
future research policies and strategies in such a way as to promote greater utilisation. 
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CHAPTER 5: ASSESSMENT OF THE UTILISATION OF RESEARCH IN HEALTH 
POLICY-MAKING 
 
5.1 The Purposes of Assessment 
Before showing how all the previous analysis could be built upon in the generation of 
appropriate tools for the assessment of the nature and extent of knowledge utilisation in 
health policy-making, it is desirable to consider the purposes of such assessments. The 
purpose of the assessment is likely to differ depending on the level at which it is conducted. 
 
Buxton and Hanney [14,15] identified three main reasons for undertaking their case study, 
and more general, assessments of the benefits from research: 
• justifying spending resources on health research; 
• assisting with the prioritisation of future expenditure; 
• indicating ways to improve the conduct and management of research so as to increase 
the likelihood or magnitude of subsequent beneficial consequences. 
 
These considerations are particularly relevant when the assessment is related to the 
justification of, and accountability for, funding at a national level, even if the case studies are 
conducted at project or research unit level. For a body such as the WHO, there could well be 
an important role in conducting such assessments with the aim of providing evidence of the 
possibility of the effective use of research resources. This could support advocacy for 
greater resources to be made available for health research. Such advocacy has recently 
been powerfully made as part of the report from WHO’s Commission on Macroeconmics and 
Health [138]. This report is seen as convincing [139], and thus perhaps is helping to 
generate a more promising climate in which research utilisation could be assessed. Cross-
national studies of research utilisation around common themes might be the best way to 
conduct assessments that could illustrate effective ways in which health research can be 
used. Understanding could be gained from the comparisons between and within countries. 
The potential link with advocacy would be strengthened if the policies on which the studies 
were based were specifically in those areas where the Commission is calling for increased 
research funding. These areas include: reproductive health, maternal and child health, 
tropical diseases, and health systems research. 
 
We noted previously the increasing WHO focus on the importance of research informing key 
policy areas [3;21]; this perspective is shared by WHO regions, for example, in relation to 
policies for improving health equity [140]. In this context it is important to recognise the 
 
 
 
 
 
 
34 
 
claim, made in section 4.5 above, that assessment can influence the activities given priority 
by researchers. This is likely to be particularly relevant when the focus of the evaluation is 
the performance of specific research units, teams, or even individuals, especially when 
funding is at stake. Given this, it is argued that moves towards giving more importance to the 
assessment of utilisation of health research should help encourage researchers to devote 
effort to activities likely to stimulate impact, and reward those who are already doing so 
[7,29,136]. The greater the significance of the assessment, however, the more dispute there 
will be over the methods to use.  
 
In particular, the role of numerical indicators needs to be considered in relation to the 
purposes of the assessment. It is argued that if the indicators used in performance 
evaluation lack ‘decision relevance’ they are ignored [141]. The introduction of performance 
indicators into a  process such as research may, however, have a dysfunctional impact 
unless great care is taken to establish the purposes and likely consequences of 
assessments [13,18]. For example, an assessment system that resulted in more 
dissemination in general, as opposed to more targeted dissemination of relevant knowledge, 
would be repeating the dangers of increasing the overload on policy-makers [105]. Where 
indicators are involved, they can be used as either ‘dials’ to measure inputs and outputs 
accurately, or as ‘tin openers’ to identify issues needing further examination or to aid 
judgement [142]. Although the use of numerical indicators as dials has been advocated by 
some, in an area such as the assessment of research and its utilisation in policy-making, 
where measurements are so difficult to make, caution is usually recommended [13,18,142]. 
It would seem only sensible to use indicators as tin openers to aid judgements when the 
purpose of the assessment involves funding decisions.  
 
Even when funding is not an issue, if any comparisons, especially international, are to be 
made, there would be dangers in using simple indicators outside of a wider qualitative 
assessment. They would become de-contextualised. The long-standing fears about such an 
assessment process include the danger of manipulation through collusion and the difficulty 
of making comparisons across programmes with a different composition of user groups [13]. 
Depending on the purpose of the assessment there is, nevertheless, scope for innovative 
thinking in terms of methods. 
 
5.2  Methods for Assessment  
Appropriate methods for assessment therefore have to be developed to reflect:  
• the purposes for which the assessment is to be conducted, for example, to increase 
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accountability, or to support advocacy for health research;  
• the analysis about the various types of research, the range of utilisation possibilities, and 
the wider conceptual frameworks, for example, the interfaces and receptors model; and 
• the different roles that can be played by retrospective assessments and ones that focus 
on the current position. 
 
Various lists have been produced of the type of information that could be gathered to 
produce numerical indicators to inform either self-evaluation/peer review of research teams 
[136], or to inform regular monitoring of the benefits from work originating from a particular 
health research funder [12,18]. Items from these lists relevant for policy-making include a 
numerical record of: presentations to policy-makers; production of fact sheets; membership 
of advisory committees; and membership of committees issuing a policy document or a 
treatment guideline. These are not really measures of actual impact and although one such 
measure, references in policy publications, was also proposed, the list would probably need 
to be supplemented; in the case of regular monitoring, for example, by a set of structured 
case studies. When an evaluation within a country is to be used for making funding 
decisions, it would be unwise to use the numerical indicators as dials because of the 
contextual issues and possible biases described above. Instead they should be used to 
inform judgements. 
 
Nor would it be sensible to use such indicators in any cross-national comparative study 
unless they were informing wider qualitative studies. Furthermore, to understand the peculiar 
difficulties of using raw questionnaire data in relation to assessing research utilisation in 
policy-making on specific issues, it is helpful to return to the definition of policy-making given 
earlier. This emphasised that those who make policies are in a particular, authoritative, 
position. This presents a rather different set of circumstances from those encountered when 
assessing utilisation of specific findings by practitioners and members of the public. In such 
cases a sample might be thought to be representative of a wider group, and individual 
characteristics and circumstances might even out within the sample. Moreover, it could be 
claimed that the opinions of each practitioner or member of the public are equally valid as 
regards the influence of research upon their own behaviour. In a study of policy-making on a 
specific issue, by contrast, the interviewees or questionnaire respondents will be likely to 
include some representatives from relevant interest groups, commentators, and researchers 
as well as policy-makers with varying degrees of involvement in different aspects of the 
making of that policy. In relation to understanding the processes involved in the policy-
making, therefore, the respondents might have conflicting views that do present truthful 
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representations of what people saw and heard. Nevertheless, depending on the 
respondent’s degree of involvement with the specific events under consideration, these 
views are likely to be of varying validity in relation to providing an account of the key actions. 
 
Such complexities no doubt help explain why qualitative interviewing and documentary 
analysis were used most frequently the research utilisation studies described in the review of 
previous work. Questionnaires could provide some information from a wider range of 
informants than it might be possible to interview. They could also be used to help identify 
aspects on which to focus detailed parts of the interviewing.  In-depth interviews, however, 
are widely seen as the most appropriate method when there is a need to unravel situations 
with diverse layers and subtle nuances. According to Rossi et al, ‘whereas written surveys 
and questions might be useful for some limited purposes, that approach lacks the flexibility 
to tailor the line of discussion to the expertise of the individual, probe and explore issues in 
depth, and engage the informant in careful reflection’ [143]. The growth of health policy and 
systems research suggests there is an increasing number of researchers who could 
undertake such interviewing [122]. 
 
Our review of previous studies demonstrated the great difficulties of making generalisations 
about specific factors associated with high levels of utilisation. To address this in any cross-
national initiative it would be useful to adopt several strategies. First, as far as possible, 
structure all the assessment studies around a conceptual framework such as the interfaces 
and receptor framework presented earlier in the report. The framework is probably sufficiently 
broad to allow it to be applied to many situations. It would, nevertheless, help inform any 
interview schedule so as to ensure the questions were focusing on both how research 
findings were communicated across the interfaces, and the degree of policy-maker 
receptivity to them. This would be done not to provide a check-list of items that it is expected 
would all have to be present if research utilisation is to be achieved. Rather, it would be so 
that the interview covered a range of items, some of which might emerge as the reasons 
linked to utilisation, or lack of it, in each particular study.  
 
The second strategy would be to base the studies on common policy themes as far as 
possible. Possible specific topics within the areas identified in the previous section include 
multi-drug therapy for leprosy and equitable access to health services. For each of the 
common themes, a key body of international research would be identified and some of the 
analysis would relate to that, and some to the impact of the full body of research available to 
policy-makers in the specific country. Some of the potential purposes the WHO might have in 
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conducting such a cross-national assessment were set out above. An approach that uses 
common elements in several detailed studies, but which also expects each study to produce 
its own narrative or story of what caused research utilisation in the particular situation and 
context, has similarities to broader approaches to the study of innovation and organisational 
change [144]. 
 
Analysis of documents and semi-structured interviews would appear to be appropriate 
methods to use in a retrospective study of research impact on policy-making related to 
specific issues, especially where the policy is made at national or sub-national government 
level. Indeed, the recently conducted systematic review recommended that future research in 
this field, ‘should combine interviews with document analysis’ [22]. Questionnaires could also 
have a role, particularly in securing a wide range of opinions about the current situation 
regarding knowledge sources for research utilisation in policy-making and the relevant HRS 
mechanisms. A combination of these approaches would provide triangulation of methods and 
data-sources. The account below focuses particularly on four main elements of the 
recommended methods for the retrospective part of the policy-making element of the 
Structured Cross-national Thematic Studies that could be undertaken in the WHO research 
utilisation project [24]: 
• documentary analysis; 
• interviews; 
• application of scales reporting the level of research utilisation in policy-making; 
• overall analysis. 
 
Documentary analysis. Documentary analysis would be undertaken in each study. Initially it 
would be used in an attempt to identify the degree of consistency between the policy in the 
country and the body of international research that is being centrally collated by the WHO 
utilisation project team. Further documentary analysis would also cover issues such as how 
far policy-makers drew on research findings in speeches during the policy formulation and 
implementation stages, and accounts in reports from research funding bodies of their efforts 
at developing mechanisms to enhance research utilisation. The documentary data-sources 
would include: research publications and reports; legislation; administrative/executive 
regulations or orders; reimbursement arrangements; guidelines/advice; meeting reports and 
minutes (if available); policy statements, speeches, and articles; and reports from research 
funding bodies. Appendix 1 sets out a draft protocol for the first element of the documentary 
analysis. 
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Interviews. A stakeholder analysis could identify whom to interview first, and then snowball 
techniques, together with review of the questionnaires, would ensure other key people were 
approached for an interview. In devising the semi-structured interview schedule to be used 
for all interviews, in all the countries participating in a cross-national study, it would be most 
important to allow interviewer flexibility. This would be necessary to deal with local 
circumstances and with situations, as described above [79], where the interviewee has a 
much more limited conception of research informed policy than the interviewer. Despite these 
caveats it would also be desirable to develop a semi-structured interview schedule that 
covered as many as possible of the points discussed in the previous analysis. Appendix 2 
consists of a draft semi-structured interview schedule, but it would have to be administered 
with considerable flexibility. 
 
The interviews would allow: 
• comparability across themes and countries yet sensitivity to specific contexts; 
• detailed investigation of the level of research impact, in relation to the particular issue, on 
the three stages of the policy-making process: agenda setting; policy formulation; and 
implementation; 
• rolling triangulation ie using later interviews to test information gathered during earlier 
ones; 
• investigation of key HRS and other mechanism that operated at the interfaces  to 
enhance the responsiveness of the receptors, including: priority setting and research 
commissioning mechanisms; the creation of research centres and facilitating links with 
policy-makers; encouraging and funding research brokerage/translator/promoter 
activities; encouraging and funding reviews and syntheses of relevant research findings 
and the production of policy briefs; and facilitating interaction between researchers and 
policy-makers at long-standing committees or one-off seminars etc;  
• investigation of a wide range of other relevant issues: the role of key institutions and their 
mechanisms, such as policy analysis, for absorbing research and their exposure to forces 
in addition to research findings; the responsiveness of policy-makers to different types 
and sources of research knowledge; the features of specific research findings that made 
policy-makers more responsive to their findings; the aspects of policy-making where 
research was seen as most valuable; the role of networks, international bodies, 
practitioner and advocacy groups, NGOs, the media and the public in bringing research 
findings into the policy debate; and developments in the wider political system; 
• collection of data for the wider assessment in the overall utilisation project about how far 
any research-informed policy formulation and implementation was contributing to an 
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increase in any of the final outcomes such as health and health equity gains. 
 
Application of scales describing the level of research utilisation in policy-making. 
Whilst there are reservations about the extent to which numerical indicators should be used 
for cross-national comparisons, it is possible to see how the type of exercises undertaken by 
Buxton and Hanney [106], Jacob and McCregor [75] and Lavis et al [11] could be built upon. 
It might be possible to develop indicators in the form of descriptive scales of the degree of 
utilisation. These would be used to give an account of the impact of research on the policy-
making in the specific context of each of the countries participating in the WHO research 
utilisation project. In the three studies cited above, the scoring or coding for each example 
was undertaken by the same team. Even clearer agreement about interpretation of scales 
would be necessary in an international exercise. Before starting any initiative, it would be 
desirable for the scales to be agreed between the assessment teams in the participating 
countries. 
  
The previous analysis indicates that it would probably be appropriate to consider developing 
four scales to apply to research utilisation in each policy area. The first scale would focus on 
a slightly narrower range of research that, as noted above, would be the international 
research. This would examine the consistency between the research and the policy. 
Previous studies illustrate, however, that consistency with research findings does not 
necessarily demonstrate that the particular findings influenced the policy [14]. Where the 
policy consists of a clinical guideline developed by a professional group there could be 
circumstances in which the first scale on the degree of consistency, based on documentary 
analysis, might be the only scale appropriate to apply. In such circumstances the analysis 
should probably concentrate on the quality of the evidence used in the guidelines [145]. 
 
The remaining three scales would each relate to assessing the actual role played by 
research in each of the three phases of policy-making described previously. The relationship 
between policy-making and research is often messy and varied. Therefore, it is inevitable 
that some research might play a part in only one of these three phases, but other research 
might play several roles. For example, epidemiological research might cause an issue to be 
placed on the policy agenda, other research that developed a specific way of improving 
treatment could be used in policy formulation, but might also have helped force the issue 
onto the policy agenda by showing improvements were possible. The details of each scale 
are set out in Appendix 3, but the issues covered in them are described here: 
1. Consistency of policy with research findings. This scale would relate to how far the 
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content of the policy on issue X was in agreement with the findings from a defined body 
of international research (irrespective of the actual degree of influence of research on 
the policy formulation). It would initially be applied during the documentary analysis. 
2. Degree of influence of research on policy agenda setting. This scale would relate to 
the extent to which research (including local research) had been responsible for getting 
the issue onto the policy-makers’ agenda. It would cover research that: either showed 
the existence/extent of a problem; or was so dramatic/decisive that it instigated action to 
be taken to turn it into policy; or contained findings/theoretical frameworks that gradually 
changed the perception of policy-makers and others as to the importance of the issue in 
a process of enlightenment. It would rely on interviews, questionnaires and 
documentary analysis. 
3. Degree of influence of research on policy formulation. This scale would relate to the 
actual influence the research had in the policy formulation process. It would aim not only 
to confirm any instrumental use of the research (ie direct use of the findings or research 
theories in formulating the content of the policy) but also to capture examples of the 
much wider range of possible impacts on policy, including the gradual sedimentation of 
insights, theories, concepts and perspectives in the enlightenment mode. This scale 
would consider the utilisation of research both in the actual development of the policy 
content, and in policy discussions and debates. The scale would be based primarily on 
the data from the interviews, but also use survey and documentary data. 
4. Degree of influence of research on policy implementation. The key issues for this 
scale would be the use of research in assisting implementation, either through findings 
which are used to inform decisions about how best to implement the policy, or by 
providing justification of the policy and being used to generate support for it in terms of 
financial resources, political commitment, and public opinion. The scale would be based 
on data primarily from interviews and documentary analysis. 
 
Overall analysis. The interviews, questionnaires, and documentary analysis should also 
provide material to help identify the relative importance, in relation to the level of utilisation 
recorded, of each of the HRS mechanisms listed in the bullet point above. The types and 
sources of research used, and reasons for their use, should also be recorded and attempts 
made to correlate them with the previous priority setting approaches. It would be appropriate 
to enhance the internal validity of the judgements about the list and the scales by discussing 
the emerging findings with the respondents. The account of each study would also involve 
description both of the value given to research in the country and of the broader cultural and 
socio-political environment, to the extent that they seem relevant to the degree of research 
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utilisation achieved. 
 
The findings from the assessments in each participating country could be collated. For each 
research theme the analysis would compare two sets of data: the scales for level of utilisation 
in each country, and the contextualised lists of the HRS activities and other mechanisms and 
networks thought to be important. Organising the studies around common themes might 
assist assessment of how far the use of the international stock of knowledge was dependent 
on local research. 
 
As noted previously, although the account here has focused on research impact on policy-
making, the evaluations would be stronger as part of a wider analysis covering research 
utilisation and interactions with practitioners, industry and the public. The fuller analysis 
would be both most useful in itself, and provide greater understanding of the environment in 
which the policy-making occurred. By building on the framework described in Figure 1, it 
should provide a holistic approach [112] to these issues. Thus, the WHO research utilisation 
project was conceived as an integrated whole in which retrospective assessment of research 
utilisation in policy-making would examine one step in a process that should eventually lead 
to health and health equity gains [24]. 
 
Given appropriate and targeted topic and country selection, this approach is likely to meet 
the purpose of using structured methods to provide examples of effective research 
utilisation. It should contribute towards enhanced understanding of the issues and could 
provide the basis of an assessment tool which, if used widely in countries, could give a boost 
to the importance attached to the utilisation of health research. 
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APPENDIX 1: ELEMENTS OF A PROTOCOL FOR DOCUMENTARY ANALYSIS 
 
We set out below the possible elements of a protocol for the documentary analysis that 
would be undertaken in each study to attempt to identify the degree of consistency between 
the policy and the body of relevant international research that is being centrally collated by 
the WHO utilisation project team. (Additional, more routine, documentary analysis would be 
undertaken as appropriate, for example, as part of the preparation for interviews and when 
collating data for the application of the scales). Before being implemented, the protocol 
would need to be reviewed and agreed between the assessment teams from each country. 
Some of the key steps would be: 
 
1. Clarification of who would undertake the identifications and comparisons described 
below: either the assessment team or, if necessary, experts in the particular field. At 
least two opinions would be sought for each policy document. 
 
2. Identification of the appropriate policy documents. This would vary by level of policy-
making (national/sub-national, institutional, clinical unit or professional body) and also by 
type of policy. The spectrum of policy types described in Chapter 2 would be reflected in 
the spectrum of possible policy documents, which includes: legislation, 
administrative/executive regulations or orders, reimbursement arrangements, 
guidelines/advice etc. 
 
3. Examination of the consistency of content between the policy documents and the 
international research findings, taking account of the following issues: 
¾ The amount of the policy that was consistent with the research; 
¾ How far the policy included the key issues covered by the research (as identified by the 
central analysis of the body of research); 
¾ How far the policy included the elements of research regarded as providing the strongest 
evidence (as identified by the central analysis using, where appropriate, grading criteria  
[145]); 
¾ How far the policy was consistent with research in terms of: the definition of the policy 
problem; definition of objectives; and the description of strategies and actions; 
¾ How far elements of the policy contradicted the research evidence. 
 
4. Initial application of the scale of the degree of consistency between policy and 
research—see Appendix 3. In applying the scale, the five factors listed in point 3 above 
would be taken into account. Where the policy consists of a clinical guideline developed 
by a professional group there could be circumstances in which this scale on the degree 
of consistency, based on documentary analysis, might be the only scale appropriate to 
apply. In such circumstances, the analysis should probably concentrate on the quality of 
the evidence used in the guidelines. Here again grading criteria could become important 
[145]. If the main assessment for clinical guidelines is going to be through documentary 
analysis, it would probably be worth extending the focus beyond the international body of 
research literature that it is proposed be used for most documentary analysis. In addition, 
local research should probably be included because it could be important to see how far 
attempts had been made to ensure the guidelines were relevant for local circumstances. 
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APPENDIX 2: DRAFT INTERVIEW SCHEDULE FOR ASSESSING RESEARCH 
UTILISATION IN POLICY-MAKING 
 
Before being implemented, the schedule would need to be reviewed by the assessment 
teams from each country with the aim of achieving at least a reasonable level of consensus 
about its broad outlines. The precise format for the questions to be asked in this 
retrospective assessment will vary depending on: who the main policy-makers turn out to be 
(government ministers; officials/administrators in executive positions; legislators; leading 
professionals etc); the level at which the policy-making occurred; the role of the individual 
interviewee; and the circumstances of policy-making in each country. The following, 
however, provides an indication of the issues that should be addressed in the semi-
structured interview so as to capture material that would be needed to construct the scales 
describing the level of utilisation. The schedule would also provide material to help identify 
the relative importance, in relation to the level of utilisation recorded, of each of the HRS 
mechanisms listed in the bullet point in section 5.2 above. It would further allow exploration 
of: the types of research that were most important; the features of specific studies that made 
them useful; aspects of the policy debate for which the research was most relevant and 
useful; and the ways of communicating or discussing the research to which the policy-
makers were most receptive, or found most useful. Aspects of the context for the policy-
making should emerge from questions 2-6 in particular. Depending on the circumstances the 
interviewer could request access to any policy documents that might not be publicly 
available. 
 
SECTION A: BACKGROUND AND POLICY AGENDA SETTING 
1. Confirm the role of the interviewee in the policy-making process in relation to the crucial 
elements in the policy development in X field in the last X years. [The exact format of this 
question will be informed by the initial documentary analysis and review of the issue 
conducted by the assessment team, but it will be important to clarify the policies to which 
the interviewee is referring so that comparisons can be made with the comments from 
other interviewees]. 
2. What have been the main events that resulted in these issues being on the policy 
agenda? 
3. Who have been the main people, and groups, whose actions resulted in these issues 
being on the policy agenda? 
4. If not brought up in answer to question 3, explore the role of research in agenda setting: 
Did research show the existence/extent of a problem? Were research findings so 
dramatic or decisive that they instigated action to be taken to turn them into policy? Did 
research findings or theoretical frameworks gradually change the perception of policy-
makers and others as to the nature or importance of the issue? 
 
SECTION B: WHO MAKES AND INFLUENCES POLICY? 
5. Who have been the main policy-makers on this topic? 
6. In the context of the response to Question 5, who had influence on the content of the 
policy? [Follow-up by asking about any individuals/groups/organisations thought to be 
important from previous interviews or the survey—these could include: ministers; the 
legislature; officials; networks; professional groups; advocacy groups; academics and 
researchers; international organisations; industry; NGOs: political parties; religious 
leaders; mass media; the pubic; and developments in the wider political system]. 
 
SECTION C: THE INFLUENCE OF RESEARCH ON POLICY FORMULATION 
7. What level of correlation do you perceive as existing between the policy and research 
findings in this field? [Explore further on the basis of the documentary analysis]. 
8. How far did research influence the policy formulation? [Use previous interviews and the 
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survey to triangulate, and explore the reasons if the response suggests research played 
a smaller role than the correlation between research and policy indicates. Check how far 
the research was drawn upon in the policy formulation, as opposed to just being 
discussed, and ask about use of research in the instrumental and enlightenment modes. 
Explore how far any theories or concepts underlining the policies could have been 
research derived].  
9. During the policy formulation how far did speeches, articles, interviews etc given by 
policy-makers draw upon research findings to support their position? 
10. For which aspects of the policy formulation did the research seem to be most relevant?  
 
SECTION D: MECHANISMS OF COMMUNICATING AND RECEIVING RESEARCH 
11. Which sources of research findings were most influential in the policy discussions? [After 
the initial response ask about any of the following as appropriate: national or 
international scientific literature; research reports; briefs of research findings produced by 
researchers; reviews/syntheses of the research literature; direct communication with 
individual researchers; attendance at seminars at which research findings were 
presented; liaison with research centres; reports from official policy/science committees; 
briefs from research brokers/promoters/translators; briefs from policy advisers or 
officials; networks consisting of interest groups and other stakeholders; mass media; and 
dialogue with international agencies]. 
12. How well equipped were the policy-makers to absorb research findings? [If not covered, 
ask about: importance of the level of training that officials/politicians have had in 
research methods; the use of policy analysis; the willingness to participate in official 
committees of policy-makers and scientists; and the degree of contact built up with 
researchers]. 
13. How important were research findings in the views of groups/organisations/individuals 
that attempted to influence the policy-making process? If not covered in the initial 
response ask about the role, and importance, of research in the views of any of the 
groups/organisations/individuals mentioned in answer to Question 6. 
 
SECTION E: RESEARCH CONTRIBUTION TO POLICY IMPLEMENTATION 
14. Once the policy had been formulated, were the research findings useful as weapons to 
help communicate the policy or to generate support for it in terms of financial resources, 
political commitment, and public opinion? Were the findings drawn upon in any speech, 
article, interview etc given by policy-makers to support the policy? 
15. Were any research findings of help in demonstrating how the policy could best be 
implemented and did they inform any decisions made at the implementation stage? 
 
SECTION F: ASPECTS OF RESEARCH RELATED TO LEVEL OF UTILISATION 
16. How far was the most relevant research that coming from specific research centres, 
and/or from research programmes and projects funded following a priority setting 
process that involved the participation of policy-makers?  
17. In the whole policy-making process, which types of research proved to be most useful? 
[After initial the response, explore the national/international dimension, and the following 
types of research: biomedical; clinical; epidemiological; health services and policy; 
economic; and evaluative]. 
18. Were the research efforts directed towards the most critical aspects of the policy? 
19. Were there any aspects of the policy debate where more research-based information 
would have been useful? 
20. Was enough funding invested in research in proportion to the total costs of the policy in 
question, and what were the main obstacles to increasing the investment? 
21. How important a factor in the degree of research utilisation were features of the specific 
research studies, including their quality and timeliness? 
22. Were there any reasons why the research did not influence the policy to the extent that it 
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could have done? 
23. To which sources of information on this issue were you personally most receptive? 
 
SECTION G: THE WIDER FOCUS 
24. How far do you think implementation of the policy has resulted in final outcomes being 
achieved in terms of health gains, health equity gains, and economic and social 
benefits? 
25. What factors do you believe could make policy-makers more receptive to research?  
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APPENDIX 3: DRAFT SCALES OF THE LEVEL OF RESEARCH UTILISATION IN 
HEALTH POLICY-MAKING 
 
The scales below represent a draft version and would need to be reviewed and agreed 
between the assessment teams from each country. It would be necessary to develop a 
shared concrete understanding of what each level means. It is proposed that the scales 
would be applied by the assessment team in each country following the gathering of the data 
in each case. The first scale would provisionally be determined by the team undertaking the 
documentary analysis but could be subject to review as a result of the further analysis. The 
protocol for the documentary analysis (scale 1) is set out in Appendix 1. For scales 2-4 the 
assessment teams would have to take into account not only the number of interviewees and 
survey respondents who held particular views, but also the likely validity of their comments. 
Further documents that could be drawn upon at this stage include: documents from interest 
and advocacy groups; reports from research funding bodies; and speeches, articles, 
interviews etc given by policy-makers in which they drew upon research findings to support 
their position during policy formulation or implementation. The research findings being 
considered in scale 1 are more restricted than in scales 2-4. Therefore, it is possible to see 
scale 1 as fitting more into the category of studies that start with specific research findings, 
and scales 2-4 being closer to the studies that start with a policy area and examine the 
degree of influence research has had upon it. 
 
 
1. Consistency of policy with research findings 
       (From analysis of policy documents) 
 
This scale would relate to how far the content of the policy on issue X was in agreement with 
the findings from a defined body of international research (irrespective of the actual degree of 
influence of research on the policy formulation). It would initially be applied during the 
documentary analysis: 
 
a) There is a considerable level of agreement between the policy and the findings of the 
research. 
b) There is a moderate level of agreement between the policy and the findings of the 
research. 
c) There is a limited level of agreement between the policy and the findings of the research. 
d) Despite the existence of relevant research, there is no indication of consistency between 
the research and policy. 
 
 
2. Degree of influence of research on policy agenda setting 
       (From interviews/survey/documentary analysis) 
 
This scale would relate to the extent to which research (including local research) was 
responsible for getting the issue onto the policy-makers’ agenda. It would cover research 
that: either showed the existence/extent of a problem; or was so dramatic/decisive that it 
instigated action to be taken to turn it into policy; or contained findings/theoretical frameworks 
that gradually changed the perception of policy-makers and others as to the importance of 
the issue through a process of enlightenment. It would rely on interviews, documentary 
analysis and questionnaires: 
 
a) Research findings were of considerable influence in causing the issue to get onto the 
policy-makers’ agenda. This could be either through showing the existence/extent of a 
problem, or through a process of enlightenment in which the findings or theoretical 
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frameworks gradually changed the perception of policy-makers and others as to the 
nature or importance of the issue, or through the findings themselves instigating action to 
be taken to turn them into policy. 
b) Research findings were of moderate influence in causing the issue to get onto the policy-
makers’ agenda through showing the existence/extent of a problem, or through a 
process of enlightenment.  
c) Research findings had a limited influence in causing the issue to get onto the policy-
makers’ agenda through showing the existence/extent of a problem or through a process 
of enlightenment. 
d) Despite the existence of relevant research, there is no indication of research influence on 
the policy. 
 
 
3. Degree of influence of research on policy formulation 
      (From interviews/survey/documentary analysis) 
 
This scale would relate to the actual influence the research had in the policy formulation 
process. It would aim not only to confirm any instrumental use of the research (ie direct use 
of the findings or research theories in formulating the content of the policy) but also to 
capture examples of the much wider range of possible impacts on policy, including the 
gradual sedimentation of insights, theories, concepts and perspectives in the enlightenment 
mode. This scale would consider the utilisation of research both in the actual development of 
the policy content, and in policy discussions and debates. The scale would be based 
primarily on the data from the interviews, but also use survey and documentary data: 
 
a) Research findings and/or research-based theory had considerable influence on the 
content of the policy in a direct, instrumental way. 
b) The research had a moderate influence on the policy. This could have been in terms of 
an instrumental impact from the findings or more in the enlightenment mode of a gradual 
percolation of concepts, insights, perspectives etc. 
c) The research had a limited influence in terms of instrumental impact or in the 
enlightenment mode, or by playing some part in the policy discussions or debates. 
d) Despite the existence of relevant research, there is no indication of research influence on 
the policy. 
 
 
4. Degree of influence of research on policy implementation 
      (From interviews/documentary analysis/survey) 
 
The key issues for this scale would be the use of research in assisting implementation, either 
through findings specifically about how best to implement the policy, or by providing 
justification of the policy and being used to generate support for it in terms of financial 
resources, political commitment, and public opinion. The scale would be primarily based on 
data from interviews and documentary analysis: 
 
a) Research findings had a considerable influence on helping implementation of the policy, 
either through findings which are used to inform decisions about how best to implement 
the policy, or by providing justification of the policy and being used to generate support 
for it in terms of financial resources, political commitment, and public opinion.  
b) The research had a moderate influence on helping implementation of the policy either 
through findings which are used to inform decisions about how best to implement the 
policy, or by providing justification of the policy and being used to generate support for it 
in terms of financial resources, political commitment, and public opinion.  
c) The research had a limited influence in helping implementation of the policy either 
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through findings which are used to inform decisions about how best to implement the 
policy, or by providing justification of the policy and being used to generate support for it 
in terms of financial resources, political commitment, and public opinion.  
d) Despite the existence of relevant research, there is no indication of research influence on 
the policy. 
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